<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/265388-ophthalmic-devices-comprising-photochromic-materials-with-reactive-substituents by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 04:27:30 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 265388:OPHTHALMIC DEVICES COMPRISING PHOTOCHROMIC MATERIALS WITH REACTIVE SUBSTITUENTS</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">OPHTHALMIC DEVICES COMPRISING PHOTOCHROMIC MATERIALS WITH REACTIVE SUBSTITUENTS</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>Ophthalmic devices comprising photochromic materials comprising a reactive substituent. For example, the present disclosure contemplates ophthalmic devices comprising photochromic materials, such as photochromic naphthopyrans and indeno-fused naphthopyrans having a reactive substituent comprising a reactive moiety linked to the photochromic naphthopyran by one or more linking groups. In certain non-limiting embodiments, the reactive moiety comprises a polymerizable moiety. In other non-limiting embodiments, the reactive moiety comprises a nucleophilic moiety. Other non-limiting embodiments of the present disclosure relate to methods of making the photochromic ophthalmic device, wherein the photochromic ophthalmic devices comprise the photoc...</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>OPHTHALMIC DEVICES COMPRISING PHOTOCHROMIC MATERIALS<br>
WITH REACTIVE SUBSTITUENTS<br>
BACKGROUND<br>
[001] Various non-limiting embodiments of the present disclosure relate to<br>
ophthalmic devices comprising photochromic materials comprising a reactive<br>
substituent. Other non-limiting embodiments of the present disclosure relate to<br>
photochromic ophthalmic devices, and methods of making the photochromic<br>
ophthalmic devices, wherein the photochromic ophthalmic devices comprise the<br>
photochromic materials described herein.<br>
[002] Many conventional photochromic materials, such as, for example,<br>
photochromic naphthopyrans, can undergo a transformation from one state to<br>
another in response to the absorption of electromagnetic radiation. For example,<br>
many conventional photochromic materials are capable of transforming between a<br>
first "clear" or "bleached" ground state and a second "colored" activated state in<br>
response to the absorption of certain wavelengths of electromagnetic radiation (or<br>
"actinic radiation"). As used herein the term "actinic radiation" refers to<br>
electromagnetic radiation that is capable of causing a photochromic material to<br>
transform from one form or state to another. The photochromic material may then<br>
revert back to the clear ground state in response to thermal energy in the absence of<br>
actinic radiation. Photochromic articles and compositions that contain one or more<br>
photochromic materials, for example photochromic lenses for eyewear applications,<br>
generally display clear and colored states that correspond to the photochromic<br>
material(s) that they contain. Thus, for example, eyewear lenses that contain<br>
photochromic materials can transform from a clear state to a colored state upon<br>
exposure to actinic radiation, such as certain wavelengths found in sunlight, and can<br>
revert back to the clear state in the absence of such radiation.<br>
[003] When utilized in photochromic articles and compositions, conventional<br>
photochromic materials are typically incorporated into a host polymer matrix by one<br>
of imbibing, blending and/or bonding. For example, one or more photochromic<br>
materials may be intermixed with a polymeric material or precursor thereof, and<br>
VTN5080<br><br>
- 2 -<br>
thereafter the photochromic composition may be formed into the photochromic<br>
article or, alternatively, the photochromic composition may be coated on a surface of<br>
an optical element as a thin film or layer. As used herein, the term "photochromic<br>
composition" refers to a photochromic material in combination with one or more<br>
other material, which may or may not be a photochromic material. Alternatively,<br>
the photochromic material may be imbibed into a pre-formed article or coating.<br>
[004] In certain circumstances it may be desirable to modify the compatibility of<br>
the photochromic material with the host polymer into which it is incorporated. For<br>
example, by making the photochromic material more compatible with the host<br>
polymer, it is less likely that the combination will demonstrate cloudiness or haze<br>
due to phase separation or migration of the photochromic material in the host<br>
polymer. In addition, compatibilized photochromic materials may be more soluble<br>
in the host polymer and/or more uniformly distributed throughout the polymer<br>
matrix. Further, by modifying the compatibility of a photochromic material with a<br>
host polymer, other properties of the photochromic composition, such as, but not<br>
limited to, fade and/or activation rate, saturated optical density, molar absorptivity or<br>
molar extinction coefficient, and activated color, may also be effected.<br>
Modifications to such properties may be done, for example, to match the same<br>
properties of complementary photochromic materials or to enable the use of such<br>
compounds in hydrophilic or hydrophobic coating compositions, thin films or in<br>
rigid to flexible plastic matrices.<br>
[005] One approach to modifying the compatibility of a photochromic material<br>
with a host polymer is to attach a polymerizable moiety to the photochromic<br>
material via a polyalkoxylated linking group, for example, a polyethylene glycol, a<br>
polypropylene glycol, and/or a polybutylene glycol linking group. One potential<br>
limitation of utilizing polyalkoxylated linking groups is the degree of purity of the<br>
resultant photochromic material that can be readily achieved. For example,<br>
commercially available polyglycols that may be incorporated into the linking groups<br>
of these photochromic materials may comprise mixtures of glycol chains possessing<br>
VTN5080<br><br>
-3-<br>
differing numbers of glycol units within each chain. Incorporation of these<br>
commercially available polyglycols into the photochromic material may lead to<br>
mixtures of compounds differing in chain lengths and molecular weights. This may<br>
lead to difficulty in purification, since one cannot readily separate out the desired<br>
photochromic materials in these mixtures.<br>
[006] Further, polyalkoxylated linking groups may comprise long chains<br>
containing multiple ether oxygen functionalities, which are inherently hydrophilic.<br>
While this may present certain desirable traits with regard to compatibility with the<br>
host polymer, linking groups with differing hydrophilicities, including linking<br>
groups that may be hydrophobic or, alternatively, linking groups of shorter length,<br>
may provide for different interactions with the host polymer and the resultant<br>
photochromic article.<br>
[007] Accordingly, for some applications it may be desirable to develop<br>
photochromic materials that may be incorporated into a variety of host polymers and<br>
which may comprise one or more reactive substituents having polarities (i.e.<br>
hydrophilicities or lipophilicities) that may more closely match the polarities of the<br>
host polymer. In other applications, it may be desirable to develop photochromic<br>
materials comprising one or more reactive substituent having polarities that do not<br>
match the polarities of the host polymers. In addition, it may be advantageous to<br>
develop photochromic materials comprising reactive substituents of uniform<br>
composition/molecular weight that can be readily purified, such as, by<br>
crystallization, chromatography, or other methods of purification known to one<br>
skilled in the art.<br>
BRIEF SUMMARY<br>
[008] Various non-limiting embodiments disclosed herein relate to ophthalmic<br>
devices comprising photochromic materials. In one non-limiting embodiment the<br>
photochromic material comprises a photochromic naphthopyran and at least one<br>
VTN5080<br><br>
-4-<br>
reactive substituent bonded to the photochromic naphthopyran, wherein each<br>
reactive substituent is independently represented by one of:<br>
[009]	-A-D-E-G-J;<br>
-G-E-G-J;<br>
-D-E-G-J;<br>
-A-D-J;<br>
-D-G-J; and<br>
-D-J;<br>
[010] wherein: (i) each -A- is independently -C(=O)-, -OC(=O)-, -NHC(=O)-, or -<br>
CH2-; (ii) each -D- is independently: (a) a diamine residue or a derivative thereof,<br>
said diamine residue being an aliphatic diamine residue, a cyclo aliphatic diamine<br>
residue, a diazacycloalkane residue, an azacyclo aliphatic amine residue, a<br>
diazacrown ether residue, or an aromatic diamine residue, wherein a first amine<br>
nitrogen of said diamine residue forms a bond with -A- or the photochromic<br>
naphthopyran, and a second amine nitrogen of said diamine residue forms a bond<br>
with -E-, -G-, or -J; or (b) an amino alcohol residue or a derivative thereof, said<br>
amino alcohol residue being an aliphatic amino alcohol residue, a cyclo aliphatic<br>
amino alcohol residue, an azacyclo aliphatic alcohol residue, a diazacyclo aliphatic<br>
alcohol residue, or an aromatic amino alcohol residue, wherein an amine nitrogen of<br>
said amino alcohol residue forms a bond with -A- or the photochromic<br>
naphthopyran, and an alcohol oxygen of said amino alcohol residue forms a bond<br>
with -E-, -G-, or -J, or, alternatively, the amine nitrogen of said amino alcohol<br>
residue forms a bond with -E-, -G-, or -J, and the alcohol oxygen of said amino<br>
alcohol residue forms a bond with -A- or the photochromic naphthopyran; (iii) each<br>
-E- is independently a dicarboxylic acid residue or a derivative thereof, said<br>
dicarboxylic acid residue being an aliphatic dicarboxylic acid residue, a<br>
cycloaliphatic dicarboxylic acid residue, or an aromatic dicarboxylic acid residue,<br>
wherein a first carbonyl group of said dicarboxylic acid residue forms a bond with -<br>
G- or -D-, and a second carbonyl group of said dicarboxylic acid residue forms a<br>
VTN5080<br><br>
-5-<br>
bond with -G-; (iv) each -G- is independently: (a) -[(OC2H4)x(OC3H6)y(OC4H8)z]-<br>
O-, wherein x, y, and z, are each independently a number between 0 and 50, and the<br>
sum of x, y, and z ranges from 1 to 50; or (b) a polyol residue or a derivative thereof,<br>
said polyol residue being an aliphatic polyol residue, a cyclo aliphatic polyol<br>
residue, or an aromatic polyol residue, wherein a first polyol oxygen of said polyol<br>
residue forms a bond with -E-, -D-, or the photochromic naphthopyran, and a second<br>
polyol oxygen of said polyol residue forms a bond with -E- or -J; and (v) each -J is<br>
independently a group comprising a reactive moiety or residue thereof; or -J is<br>
hydrogen, provided that if -J is hydrogen, -J is bonded to an oxygen of group -D- or<br>
-G-, forming a reactive moiety.<br>
[011] Another non-limiting embodiment comprises an ophthalmic device<br>
comprising a photochromic material represented by the formula PC-[R]r, wherein (a)<br>
PC comprises a photochromic naphthopyran, wherein said photochromic<br>
naphthopyran is a 2H-naphtho[l,2-b]pyran, a 3H-naphtho[2,l-b]pyran, an<br>
indeno[2',3':3,4] naphtho[l,2-b]pyran or an indeno[l',2':4,3]naphtho[2,l-b]pyran or<br>
a mixture thereof; (b) r is an integer ranging from 1 to 4; and (c) each R is a reactive<br>
substituent independently represented by one of:<br>
-A-D-E-G-J;<br>
-G-E-G-J;<br>
-D-E-G-J;<br>
-A-D-J;<br>
-D-G-J; and<br>
-D-J;<br>
wherein: (i) each -A- is independently -C(=O)-, -OC(=O)-, -NHC(=O)-, or -CH2-;<br>
(ii) each -D- is independently: (a) a diamine residue or a derivative thereof, said<br>
diamine residue being an aliphatic diamine residue, a cyclo aliphatic diamine<br>
residue, a diazacycloalkane residue, an azacyclo aliphatic amine residue, a<br>
diazacrown ether residue, or an aromatic diamine residue, wherein a first amine<br>
nitrogen of said diamine residue forms a bond with -A- or PC, and a second amine<br>
VTN5080<br><br>
-6-<br>
nitrogen of said diamine residue forms a bond with -E-, -G-, or -J; or (b) an amino<br>
alcohol residue or a derivative thereof, said amino alcohol residue being an aliphatic<br>
amino alcohol residue, a cyclo aliphatic amino alcohol residue, an azacyclo aliphatic<br>
alcohol residue, a diazacyclo aliphatic alcohol residue, or an aromatic amino alcohol<br>
residue, wherein an amine nitrogen of said amino alcohol residue forms a bond with<br>
-A- or PC, and an alcohol oxygen of said amino alcohol residue forms a bond with -<br>
E-, -G-, or -J, or said amine nitrogen of said amino alcohol residue forms a bond<br>
with -E-, -G-, or -J, and said alcohol oxygen of said amino alcohol residue forms a<br>
bond with -A- or PC; (iii) each -E- is independently a dicarboxylic acid residue or a<br>
derivative thereof, said dicarboxylic acid residue being an aliphatic dicarboxylic acid<br>
residue, a cycloaliphatic dicarboxylic acid residue, or an aromatic dicarboxylic acid<br>
residue, wherein a first carbonyl group of said dicarboxylic acid residue forms a<br>
bond with -G- or -D-, and a second carbonyl group of said dicarboxylic acid residue<br>
forms a bond with -G-; (iv) each -G- is independently: (a)<br>
-[(OC2H4)x(OC3H6)y(OC4H8)z]-O-, wherein x, y, and z, are each independently a<br>
number between 0 and 50, and the sum of x, y, and z ranges from 1 to 50; or (b) a<br>
polyol residue or a derivative thereof, said polyol residue being an aliphatic polyol<br>
residue, a cyclo aliphatic polyol residue, or an aromatic polyol residue, wherein a<br>
first polyol oxygen of said polyol residue forms a bond with -E-, -D-, or PC, and a<br>
second polyol oxygen of said polyol residue forms a bond with -E- or -J; and (v)<br>
each -J is independently a group comprising acryl, crotyl, methacryl, 2-<br>
(methacryloxy)ethylcarbamyl, 2-(methacryloxy) ethoxycarbonyl, 4-vinylphenyl,<br>
vinyl, 1-chlorovinyl, or epoxy; or -J is hydrogen, provided that if-J is hydrogen, -J<br>
is bonded to an oxygen of group -D- or -G-.<br>
[012] A further non-limiting embodiment comprises an ophthalmic device<br>
comprising a photochromic material represented by one of structures I through IV,<br>
below, or mixtures thereof.<br>
VTN5080<br><br>
-7-<br><br>
wherein,<br>
(a) R1 is: a reactive substituent R, wherein said reactive substituent R is<br>
represented by one of:<br>
-A-D-E-G-J;<br>
-G-E-G-J;<br>
-D-E-G-J;<br>
-A-D-J;<br>
-D-G-J; and<br>
-D-J;<br>
wherein<br>
-A- is -C(=O)-, -OC(=O)-, -NHC(=O)-, or -CH2-;<br>
VTN5080<br><br>
-8-<br>
-D- is: a diamine residue or a derivative thereof, said diamine residue being<br>
an aliphatic diamine residue, a cyclo aliphatic diamine residue, a diazacycloalkane<br>
residue, an azacyclo aliphatic amine residue, a diazacrown ether residue, or an<br>
aromatic diamine residue, wherein a first amine nitrogen of said diamine residue<br>
forms a bond with -A-, structure I, structure II, structure III, or structure IV, and a<br>
second amine nitrogen of said diamine residue forms a bond with -E-, -G-, or -J; or<br>
an amino alcohol residue or a derivative thereof, said amino alcohol residue being an<br>
aliphatic amino alcohol residue, a cyclo aliphatic amino alcohol residue, an azacyclo<br>
aliphatic alcohol residue, a diazacyclo aliphatic alcohol residue, or an aromatic<br>
amino alcohol residue, wherein an amine nitrogen of said amino alcohol residue<br>
forms a bond with -A-, structure I, structure II, structure III, or structure IV, and an<br>
alcohol oxygen of said amino alcohol residue forms a bond with -E-, -G-, or -J, or<br>
said amine nitrogen of said amino alcohol residue forms a bond with -E-, -G-, or -J,<br>
and said alcohol oxygen of said amino alcohol residue forms a bond with -A-,<br>
structure I, structure II, structure III, or structure IV;<br>
-E- is a dicarboxylic acid residue or a derivative thereof, said dicarboxylic<br>
acid residue being an aliphatic dicarboxylic acid residue, a cycloaliphatic<br>
dicarboxylic acid residue, or an aromatic dicarboxylic acid residue, wherein a first<br>
carbonyl group of said dicarboxylic acid residue forms a bond with -G- or -D-, and a<br>
second carbonyl group of said dicarboxylic acid residue forms a bond with -G-;<br>
each -G- is independently: -[(OC2H4)x(OC3H6)y(OC4H8)z]-O-, wherein x, y,<br>
and z, are each independently a number between 0 and 50, and the sum of x, y, and z<br>
ranges from 1 to 50; or a polyol residue or a derivative thereof, said polyol residue<br>
being an aliphatic polyol residue, a cyclo aliphatic polyol residue, or an aromatic<br>
polyol residue, wherein a first polyol oxygen of said polyol residue forms a bond<br>
with -E-, -D-, structure I, structure II, structure III, or structure IV, and a second<br>
polyol oxygen of said polyol residue forms a bond with -E- or -J; and<br>
-J is a group comprising acryl, methacryl, crotyl, 2-(methacryloxy)<br>
ethylcarbamyl, 2-(methacryloxy)ethoxycarbonyl, 4-vinylphenyl, vinyl, 1-<br>
VTN5080<br><br>
-9-<br>
chlorovinyl, or epoxy, or -J is hydrogen, provided that if -J is hydrogen, -J is bonded<br>
to an oxygen of group -D- or -G-;<br>
or R1 is hydrogen; hydroxyl; C1-C3 alkyl; or the group -C(=O)W, wherein W<br>
is -OR7, -N(R8)R9, piperidino or morpholino, wherein R7 is allyl, C1-C6 alkyl,<br>
phenyl, mono(C1-C6)alkyl substituted phenyl, mono(C1-C6)alkoxy substituted<br>
phenyl, phenyl(C1-C3)alkyl, mono(C1-C6)alkyl substituted phenyl(C1-C3)alkyl,<br>
mono(C1-C6)alkoxy substituted phenyl(C1-C3)alkyl, C1-C6 alkoxy(C2-C4)alkyl or<br>
C1-C6 haloalkyl; Rg and R9 are each independently C1-C6 alkyl, C5-C7 cycloalkyl,<br>
phenyl, mono-substituted phenyl, or di-substituted phenyl, wherein said phenyl<br>
substituents are C1-C6 alkyl or C1-C6 alkoxy, and said halo substituent is chloro or<br>
fluoro;<br>
(b)	R1' is: the reactive substituent R; hydrogen; hydroxyl; C1-C3 alkyl; or<br>
the group -C(=O)W, wherein W is -OR7, -N(R8)R9, piperidino or morpholino,<br>
wherein R7 is allyl, C1-C6 alkyl, phenyl, mono(C1-C6)alkyl substituted phenyl,<br>
mono(C1-C6)alkoxy substituted phenyl, phenyl(C1-C3)alkyl, mono(C1-C6)alkyl<br>
substituted phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-C3)alkyl,<br>
C1-C6 alkoxy(C2-C4)alkyl or C1-C6 haloalkyl; and R8 and R9 are each independently<br>
C1-C6 alkyl, C5-C7 cycloalkyl, phenyl, mono-substituted phenyl, or di-substituted<br>
phenyl, wherein said phenyl substituents are C1-C6 alkyl or C1-C6 alkoxy, and said<br>
halo substituent is chloro or fluoro;<br>
(c)	R2 is the reactive substituent R; hydrogen; C1-C6 alkyl; C3-C7<br>
cycloalkyl, substituted or unsubstituted phenyl; or -OR10; or -OC(=O)R10, wherein<br>
R10 is hydrogen; C1-C6 alkyl, phenyl(C1-C3)alkyl, mono(C1-C6)alkyl substituted<br>
phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-C3)alkyl, (C1-<br>
C6)alkoxy(C2-C4)alkyl, C3-C7 cycloalkyl, or mono(C1-C4)alkyl substituted C3-C7<br>
cycloalkyl, and said phenyl substituents are C1-C6 alkyl or C1-C6 alkoxy;<br>
(d)	n is an integer ranging from 0 to 4 and each R3 and R4 are<br>
independently for each occurrence: the reactive substituent R; hydrogen; fluoro,<br>
chloro, C1-C6 alkyl; C3-C7 cycloalkyl; substituted or unsubstituted phenyl; -OR10 or<br>
VTN5080<br><br>
-10-<br>
-OC(=O)R10, wherein R10 is hydrogen, C1-C6 alkyl, phenyl(C1-C3)alkyl, mono(C1-<br>
C6)alkyl substituted phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-<br>
C3)alkyl, (C1-C6)alkoxy(C2-C4)alkyl, C3-C7 cycloalkyl, or mono(C1-C4)alkyl<br>
substituted C3-C7 cycloalkyl, and said phenyl substituents are C1-C6 alkyl or C1-C6<br>
alkoxy; a mono-substituted phenyl, said phenyl having a substituent located at the<br>
para position, wherein the substituent is: a dicarboxylic acid residue or derivative<br>
thereof, a diamine residue or derivative thereof, an amino alcohol residue or<br>
derivative thereof, a polyol residue or derivative thereof, -CH2-, -(CH2)t-, or -[O-<br>
(CH2)t]k-, wherein t is an integer 2, 3, 4, 5 or 6 and k is an integer from 1 to 50, the<br>
substituent being connected to an aryl group on another photochromic material;<br>
-N(R11)R12, wherein R11 and R12 are each independently hydrogen, Ci-Cg alkyl,<br>
phenyl, naphthyl, furanyl, benzofuran-2-yl, benzofuran-3-yl, thienyl, benzothien-2-<br>
yl, benzothien-3-yl, dibenzofuranyl, dibenzothienyl, benzopyridyl, fluorenyl, C1-C8<br>
alkylaryl, C3-C20 cycloalkyl, C4- C20 bicycloalkyl, C5- C20 tricycloalkyl or C1- C20<br>
alkoxyalkyl, wherein said aryl group is phenyl or naphthyl, or R11 and R12 come<br>
together with the nitrogen atom to form a C3-C20 hetero-bicycloalkyl ring or a C4-C20<br>
hetero-tricycloalkyl ring; a nitrogen containing ring represented by the following<br>
graphic formula VA: <br>
VA<br>
wherein each -Y- is independently chosen for each occurrence from -CH2-,<br>
-CH(R13)-, -C(R13)2-, -CH(aryl)-, -C(aryl)2-, and -C(R13)(aryl)-, and Z is -Y-, -O-, -<br>
S-, -S(O)-, -SO2-, -NH-, -N(R13)-, or -N(aryl)-, wherein each R13 is independently<br>
C1-C6 alkyl, each aryl is independently phenyl or naphthyl, m is an integer 1, 2 or 3,<br>
and p is an integer 0, 1, 2, or 3 and when p is 0, Z is -Y-; a group represented by one<br>
of the following graphic formulae VB or VC:<br>
VTN5080<br><br>
-11 -<br><br>
wherein R15, R16, and R17 are each independently hydrogen, C1-C6 alkyl, phenyl, or<br>
naphthyl, or the groups R15 and R16 together form a ring of 5 to 8 carbon atoms, each<br>
R14 is independently for each occurrence from C1-C6 alkyl, C1-C6 alkoxy, fluoro, or<br>
chloro and p is an integer 0, 1, 2, or 3; and unsubstituted, mono-, or di-substituted<br>
C4-C18 spirobicyclic amine, or unsubstituted, mono- or di-substituted C4-C18<br>
spirotricyclic amine, wherein said substituents are independently aryl, C1-C6 alkyl,<br>
C1-C6 alkoxy, or phenyl(C1-C6)alkyl; or<br>
an R3 group in the 6-position and an R3 group in the 7-position together form<br>
a group represented by one of VD and VE:<br><br>
wherein T and T' are each independently oxygen or the group -NR11-, where R11,<br>
R15, and R16 are as set forth above;<br>
(e) R5 and R6 are each independently: the reactive substituent R;<br>
hydrogen; hydroxy; C1-C6 alkyl; C3-C7 cycloalkyl; allyl; substituted or unsubstituted<br>
phenyl; substituted or unsubstituted benzyl; chloro; fluoro; -C(=0)W, wherein W<br>
is hydrogen, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, the unsubstituted, mono-or di-<br>
substituted aryl groups phenyl or naphthyl, phenoxy, mono- or di-(C1-C6) alkoxy<br>
substituted phenoxy, mono- or di-(C1-C6)alkoxy substituted phenoxy, amino,<br>
mono(C1-C6)alkylamino, di(C1-C6)alkylamino, phenylamino, mono- or di-(C1-<br>
C6)alkyl substituted phenylamino, or mono- or di-(C1-C6)alkoxy substituted<br>
phenylamino; -OR18, wherein R18 is C1-C6 alkyl, phenyl(C1-C3)alkyl, mono(C1-<br>
VTN5080<br><br>
-12-<br>
C6)alkyl substituted phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-<br>
C3)alkyl, C1-C6 alkoxy(C2-C4)alkyl, C3-C7 cycloalkyl, mono(C1-C4)alkyl substituted<br>
C3-C7 cycloalkyl, C1-C6 chloroalkyl, C1-C6 fluoroalkyl, allyl, or the group<br>
-CH(R19)Y', wherein R19 is hydrogen or C1-C3 alkyl and Y' is CN, CF3, or COOR20,<br>
wherein R20 is hydrogen or C1-C3 alkyl or R18 is the group -C(=O)W", wherein W"<br>
is hydrogen, C1-C6 alkyl, C1-C6 alkoxy, the unsubstituted, mono- or di-substituted<br>
aryl groups phenyl or naphthyl, phenoxy, mono- or di-(C1-C6)alkyl substituted<br>
phenoxy, mono- or di-(C1-C6)alkoxy substituted phenoxy, amino, mono(C1-<br>
C6)alkylamino, di(C1-C6)alkylamino, phenylamino, mono- or di-( C1-C6)alkyl<br>
substituted phenylamino, or mono- or di-( C1-C6)alkoxy substituted phenylamino,<br>
wherein each of said phenyl, benzyl, or aryl group substituents are independently<br>
C1-C6 alkyl or C1-C6 alkoxy; or a mono-substituted phenyl, said phenyl having a<br>
substituent located at the para position, wherein the substituent is: a dicarboxylic<br>
acid residue or derivative thereof, a diamine residue or derivative thereof, an amino<br>
alcohol residue or derivative thereof, a polyol residue or derivative thereof, -CH2-,<br>
-(CH2)r, or -[O-(CH2)t]k-, wherein t is an integer 2, 3, 4, 5 or 6 and k is an integer<br>
from 1 to 50, the substituent being connected to an aryl group on another<br>
photochromic material; or R5 and R6 together form an oxo group, a spiro-carbocyclic<br>
group containing 3 to 6 carbon atoms, or a spiro-heterocyclic group containing 1 to 2<br>
oxygen atoms and 3 to 6 carbon atoms including the spirocarbon atom, said spiro-<br>
carbocyclic and spiro-heterocyclic groups being annellated with 0, 1 or 2 benzene<br>
rings; and<br>
(f) B and B' are each independently: a substituted phenyl; a substituted<br>
aryl; a substituted 9-julolindinyl; a substituted heteroaromatic group chosen from<br>
pyridyl, furanyl, benzofuran-2-yl, benzofuran-3-yl, thienyl, benzothien-2-yl,<br>
benzothien-3-yl, dibenzofuranyl, dibenzothienyl, carbazoyl, benzopyridyl, indolinyl,<br>
and fluorenyl, wherein the phenyl, aryl, 9-julolindinyl, or heteroaromatic substituent<br>
is the reactive substituent R; an unsubstituted, mono-, di-, or tri-substituted phenyl<br>
or aryl group; 9-julolidinyl; and an unsubstituted, mono- or di-substituted<br>
VTN5080<br><br>
-13-<br>
heteroaromatic group chosen from pyridyl, furanyl, benzofuran-2-yl, benzofuran-3-<br>
yl, thienyl, benzothien-2-yl, benzothien-3-yl, dibenzofuranyl, dibenzothienyl,<br>
carbazoyl, benzopyridyl, indolinyl, and fluorenyl, wherein each of the phenyl, aryl<br>
and heteroaromatic substituents are each independently: hydroxyl, a group -<br>
C(=O)R21, wherein R21 is -OR22, -N(R23)R24, piperidino or morpholino, wherein R22<br>
is allyl, C1-C6 alkyl, phenyl, mono(C1-C6)alkyl substituted phenyl, mono(C1-<br>
C6)alkoxy substituted phenyl, phenyl(C1-C3)alkyl, mono(C1-C6)alkyl substituted<br>
phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-C3)alkyl, C1-C6<br>
alkoxy(C2-C4)alkyl or C1-C6 haloalkyl; R23 and R24 are each independently C1-C6<br>
alkyl, C5-C7 cycloalkyl, phenyl or substituted phenyl, the phenyl substituents being<br>
C1-C6 alkyl or C1-C6 alkoxy, and said halo substituent is chloro or fluoro, aryl,<br>
mono(C1-C12)alkoxyaryl, di(C1-C12)alkoxyaryl, mono(C1-C12)alkylaryl, di(C1-<br>
C12)alkylaryl, haloaryl, C3-C7 cycloalkylaryl, C3-C7 cycloalkyl, C3-C7 cycloalkyloxy,<br>
C3-C7 cycloalkyloxy(C1-C12)alkyl, C3-C7 cycloalkyloxy(C1-C12)alkoxy, aryl(C1-<br>
C12)alkyl, aryl(C1-C12)alkoxy, aryloxy, aryloxy(C1-C12)alkyl, aryloxy(C1-<br>
C12)alkoxy, mono- or di(C1-C12)alkylaryl(C1-C12)alkyl, mono- or di-(C1-<br>
C12)alkoxyaryl(C1-C12)alkyl, mono- or di-(C1-C12)alkylaryl(C1-C12)alkoxy, mono- or<br>
di-(C1-C12)alkoxyaryl(C1-C12)alkoxy, amino, mono- or di-(C1-C12)alkylamino,<br>
diarylamino, piperazine, N-(C1-C12)alkylpiperazino, N-arylpiperazino, aziridino,<br>
indolino, piperidino, morpholino, thiomorpholino, tetrahydroquinolino,<br>
tetrahydroisoquinolino, pyrrolidyl, C1-C12 alkyl, C1-C12 haloalkyl, C1-C12 alkoxy,<br>
mono(C1-C12 )alkoxy(C1-C12 )alkyl, acryloxy, methacryloxy or halogen; an<br>
unsubstituted or mono-substituted group chosen from pyrazolyl, imidazolyl,<br>
pyrazolinyl, imidazolinyl, pyrrolinyl, phenothiazinyl, phenoxazinyl, phenazinyl, and<br>
acridinyl, each of said substituents being C1-C12 alkyl, C1-C12 alkoxy, phenyl, or<br>
halogen; a mono-substituted phenyl, said phenyl having a substituent located at the<br>
para position, wherein the substituent is: a dicarboxylic acid residue or derivative<br>
thereof, a diamine residue or derivative thereof, an amino alcohol residue or<br>
derivative thereof, a polyol residue or derivative thereof, -CH2-, -(CH2)r, or -[O-<br>
VTN5080<br><br>
-14-<br>
(CH2)t]k-, wherein t is an integer 2, 3, 4, 5 or 6 and k is an integer from 1 to 50, the<br>
substituent being connected to an aryl group on another photochromic material; a<br>
group represented by one of:<br><br>
wherein each K is -CH2- or -O-, and M is -O- or substituted nitrogen, provided that<br>
when M is substituted nitrogen, K is -CH2-, the substituted nitrogen substituents<br>
being hydrogen, C1-C12 alkyl, or C1-C12 acyl, each R25 being independently chosen<br>
for each occurrence from C1-C12 alkyl, C1-C12 alkoxy, hydroxy, and halogen, R26 and<br>
R27 each being independently hydrogen or C1-C12 alkyl, and u is an integer ranging<br>
from 0 to 2; or a group represented by:<br><br>
wherein R28 is hydrogen or C1-C12 alkyl, and R29 is an unsubstituted, mono-, or di-<br>
substituted group chosen from naphthyl, phenyl, furanyl, and thienyl, wherein the<br>
substituents are C1-C12 alkyl, C1-C12 alkoxy, or halogen; or B and B' taken together<br>
form one of a fluoren-9-ylidene, mono-, or di- substituted fluoren-9-ylidene, each of<br>
said fluoren-9-ylidene substituents being independently chosen from C1-C12 alkyl,<br>
C1-C12 alkoxy, and halogen; provided that the photochromic material comprises at<br>
least one reactive substituent R.<br>
[013] Still other non-limiting embodiments relate to ophthalmic devices<br>
comprising photochromic compositions, and methods of making the same, wherein<br>
the ophthalmic devices comprise a photochromic material according various non-<br>
limiting embodiments disclosed herein.<br>
BRIEF DESCRIPTION OF THE DRAWINGS<br>
VTN5080<br><br>
-15-<br>
[014] Various non-limiting embodiments of the invention disclosed herein will be<br>
better understood when read in conjunction with the drawings, in which: Figs. 1 and<br>
2 are schematic diagrams of reaction schemes for synthesizing photochromic<br>
materials according to various non-limiting embodiments disclosed herein.<br>
DETAILED DESCRIPTION<br>
[015] As used in this specification and the appended claims, the articles "a," "an,"<br>
and "the" include plural referents unless expressly and unequivocally limited to one<br>
referent.<br>
[016] Additionally, for the purposes of this specification, unless otherwise<br>
indicated, all numbers expressing quantities of ingredients, reaction conditions, and<br>
other properties or parameters used in the specification are to be understood as being<br>
modified in all instances by the term "about." Accordingly, unless otherwise<br>
indicated, it should be understood that the numerical parameters set forth in the<br>
following specification and attached claims are approximations. At the very least,<br>
and not as an attempt to limit the application of the doctrine of equivalents to the<br>
scope of the claims, numerical parameters should be read in light of the number of<br>
reported significant digits and the application of ordinary rounding techniques.<br>
[017] Further, while the numerical ranges and parameters setting forth the broad<br>
scope of the invention are approximations as discussed above, the numerical values<br>
set forth in the Examples section are reported as precisely as possible. It should be<br>
understood, however, that such numerical values inherently contain certain errors<br>
resulting from the measurement equipment and/or measurement technique.<br>
[018] As used herein in the terms "lens" and "ophthalmic device" refer to devices<br>
that reside in or on the eye. These devices can provide optical correction, wound<br>
care, drug delivery, diagnostic functionality, cosmetic enhancement or effect or a<br>
combination of these properties. The terms lens and ophthalmic device includes but<br>
are not limited to soft contact lenses, hard contact lenses, intraocular lenses, overlay<br>
lenses, ocular inserts, and optical inserts.<br>
VTN5080<br><br>
-16-<br>
[019] Photochromic materials according to various non-limiting embodiments of<br>
the invention will now be discussed. As used herein, the term "photochromic"<br>
means having an absorption spectrum for at least visible radiation that varies in<br>
response to absorption of at least actinic radiation. Further, as used herein, the term<br>
"photochromic material" means any substance that is adapted to display<br>
photochromic properties, i.e., adapted to have an absorption spectrum for at least<br>
visible radiation that varies in response to absorption of at least actinic radiation.<br>
[020] One non-limiting embodiment provides a photochromic material comprising<br>
a photochromic naphthopyran, and a reactive substituent bonded to the<br>
photochromic naphthopyran, wherein the reactive substituent is represented by one<br>
of:<br>
-A-D-E-G-J;<br>
-G-E-G-J;<br>
-D-E-G-J;<br>
-A-D-J;<br>
-D-G-J; and<br>
-D-J.<br>
[021] Non-limiting examples of structures for -A- according to various non-<br>
limiting embodiments of the present disclosure include -C(=O)-, -OC(=O)-, -<br>
NHC(=O)-, and -CH2-.<br>
[022] Non-limiting examples of structures for -D- according to various non-<br>
limiting embodiments of the present disclosure include diamine residues or<br>
derivatives thereof, wherein a first amine nitrogen of said diamine residue forms a<br>
bond with -A- or the photochromic naphthopyran, and a second amine nitrogen of<br>
said diamine residue forms a bond with -E-, -G-, or -J and amino alcohol residues or<br>
derivatives thereor, wherein an amine nitrogen of said amino alcohol residue forms a<br>
bond with -A- or the photochromic naphthopyran, and an alcohol oxygen of said<br>
amino alcohol residue forms a bond with -E-, -G-, or -J, or, alternatively, the amine<br>
nitrogen of said amino alcohol residue forms a bond with -E-, -G-, or -J, and the<br>
VTN5080<br><br>
-17-<br>
alcohol oxygen of said amino alcohol residue forms a bond with -A- or the<br>
photochromic naphthopyran.<br>
[023] In certain non-limitnig embodiments where -D- is a diamine residue or a<br>
derivative thereof, non-limiting examples of said diamine residue include apliphatic<br>
diamine residues, cyclo aliphatic diamine residues, diazacycloalkane residues,<br>
azacyclo aliphatic amine residues, diazacrown ether residues, and aromatic diamine<br>
residues. Non-liminting examples of diamine residues from which -D- may<br>
bechosen include diamine residues represented by any of the following structures:<br><br>
[024] In other non-limiting embodiments where -D- is an amino alcohol residue or<br>
a derivative thereof, non-limiting examples of said amino alcohol residue include<br>
aliphatic amino alcohol residues, cyclo aliphatic amino alcohol residues, azacyclo<br>
aliphatic alcohol residues, dazacyclo aliphatic alcohol residues, and aromatic amino<br>
alcohol residues. Non-limiting examples of amino alcohol residues from which -D-<br>
may be chosen include amino alcohol residues represented by any of the following<br>
structures:<br>
VTN5080<br><br>
-18-<br><br>
[025] Non-limiting examples of structures for -E- according to various non-<br>
limiting embodiments of the present disclosure include dicarboxylic acid residues or<br>
derivatives thereof, wherein a first carbonyl group of said dicarboxylic acid residue<br>
forms a bond with -G- or -D-, and a second carbonyl group of said dicarboxylic acid<br>
residue forms a bond with -G-. Non-limiting examples of suitable dicarboxylic acid<br>
residues include aliphatic dicarboxylic acid residues, cycloaliphatic dicarboxylic<br>
acid residues, and aromatic dicarboxylic acid residues. Non-limiting examples of<br>
dicarboxylic acid residues from which -E- may be chosen include dicarboxylic<br>
residues represented by any of the following structures:<br><br>
[026] Non-limiting examples of structures for -G- according to various non-<br>
limiting embodiments of the present disclosure include polyalkyleneglycol residues<br>
and polyol residues and derivatives thereof, wherein a first polyol oxygen of said<br>
polyol residue forms a bond with -E-, -D-, or the photochromic naphthopyran, and a<br>
second polyol oxygen of said polyol residue forms a bond with -E- or -J. Non-<br>
VTN5080<br><br>
-19-<br>
limiting examples of suitable polyalkyleneglycol residues include the structure:<br>
-[(OC2H4)x(OC3H6)y(OC4H8)z]-O-, wherein x, y, and z, are each independently a<br>
number between 0 and 50, and the sum of x, y, and z ranges from 1 to 50. Non-<br>
limiting examples of suitable polyol residues include aliphatic polyol residues, cyclo<br>
aliphatic polyol residues, and aromatic polyol residues.<br>
[027] As discussed above, -G- can be a residue of a polyol, which is defined herein<br>
to include hydroxy-containing carbohydrates, such as those set forth in U.S. Patent<br>
No. 6,555,028 at col. 7, line 56 to col. 8, line 17, which disclosure is hereby<br>
specifically incorporated by reference herein. The polyol residue may be formed,<br>
for example and without limitation herein, by the reaction of one or more of the<br>
polyol hydroxyl groups with a precursor of-E- or -D-, such as a carboxylic acid or<br>
a methylene halide, a precursor of a polyalkoxylated group, such as polyalkylene<br>
glycol, or a hydroxyl substituent of the indenofused naphthopyran. The polyol may<br>
be represented by U-(OH)a and the residue of the polyol may be represented by the<br>
formula -O-U-(OH)a-1, wherein U is the backbone or main chain of the polyhydroxy<br>
compound and "a" is at least 2.<br>
[028] Examples of polyols from which -G- may be formed include polyols having<br>
at least 2 hydroxy groups such as (a) low molecular weight polyols having an<br>
average molecular weight less than 500, such as, but not limited to, those set forth in<br>
U.S. Patent No. 6,555,028 at col. 4, lines 48-50, and col. 4, line 55 to col. 6, line 5,<br>
which disclosure is hereby specifically incorporated by reference herein; (b) polyster<br>
polyols, such as, but not limited to, those set forth in U.S. Patent No. 6,555,028 at<br>
col. 5, lines 7-33, which disclosure is hereby specifically incorporated by reference<br>
herein; (c) polyether polyols, such as but not limited to those set forth in U.S. Patent<br>
No. 6,555,028 at col. 5, lines 34-50, which disclosure is hereby specifically<br>
incorporated by reference herein; (d) amide-containing polyols, such as, but not<br>
limited to, those set forth in U.S. Patent No. 6,555,028 at col. 5, lines 51-62, which<br>
disclosure is hereby specifically incorporated by reference; (e) epoxy polyols, such<br>
as, but not limited to, those set forth in U.S. Patent No. 6,555,028 at col. 5 line 63 to<br>
VTN5080<br><br>
-20-<br>
col. 6, line 3, which disclosure is hereby specifically incorporated by reference<br>
herein; (f) polyhydric polyvinyl alcohols, such as, but not limited to, those set forth<br>
in U.S. Patent No. 6,555,028 at col. 6, lines 4-12, which disclosure is hereby<br>
specifically incorporated by reference herein; (g) urethane polyols, such as, but not<br>
limited to those set forth in U.S. Patent No. 6,555,028 at col. 6, lines 13-43, which<br>
disclosure is hereby specifically incorporated by reference herein; (h) polyacrylic<br>
polyols, such as, but not limited to those set forth in U.S. Patent No. 6,555,028 at<br>
col. 6, lines 43 to col. 7, line 40, which disclosure is hereby specifically incorporated<br>
by reference herein; (i) polycarbonate polyols, such as, but not limited to, those set<br>
forth in U.S. Patent No. 6,555,028 at col. 7, lines 41-55, which disclosure is hereby<br>
specifically incorporated by reference herein; and (j) mixtures of such polyols.<br>
[029] In the various non-limiting embodiments of the present disclosure, -J is a<br>
group comprising a reactive moiety or residue thereof; or -J is hydrogen, provided<br>
that if-J is hydrogen, -J is bonded to an oxygen of group -D- or -G-, forming a<br>
reactive moiety.<br>
As used herein, the term "photochromic naphthopyran" is defined as a photochromic<br>
compound having a core naphthopyran substructure that displays photochromic<br>
properties. For example, according to various non-limiting embodiments, the<br>
photochromic naphthopyran is capable of transforming between a first "closed"<br>
form and a second "open" form in response to the absorption of actinic radiation.<br>
Examples of core naphthopyran substructures are presented below:<br><br>
VTN5080<br><br>
-21 -<br>
[030] According to various non-limiting embodiments disclosed herein, the groups<br>
B and B' (shown above) are part of the photochromic naphthopyran core<br>
substructure. Without intending to be limited by any particular theory, it is believed<br>
that the B and B' groups may help stabilize the open form of the core naphthopyran<br>
substructure by being in conjugation with the pi-system of the open form of the core<br>
naphthopyran substructure. Suitable structures for B and/or B' are any structures<br>
that have at least one pi-bond that is in conjugation with the pi-system of the open<br>
form of the core naphthopyran substructure, for example, but not limited to, a<br>
substituted or unsubstituted aryl ring (e.g., a substituted or unsubstituted phenyl ring<br>
or naphthyl ring), and substituted or unsubstituted heteroaromatic ring structures.<br>
Various non-limiting examples for structure B and/or B' are discussed in detail<br>
hereinbelow.<br>
[031] Photochromic naphthopyrans that are suitable for use in conjunction with<br>
various non-limiting embodiments disclosed herein, include, but are not limited to,<br>
substituted 2H-naphtho[l,2-b]pyrans, substituted 3H-naphtho[2,l-b]pyrans,<br>
substituted indeno[2',3':3,4]naphtho[l,2-b]pyrans, substituted<br>
indeno[l ',2':4,3]naphtho[2,l-b]pyrans, and mixtures thereof. Photochromic<br>
naphthopyrans having these structures are shown below in structures 1 through 4,<br>
respectively.<br>
VTN5080<br><br>
-22-<br><br>
[032] As discussed above, the photochromic materials according to various non-<br>
limiting embodiments disclosed herein, such as photochromic naphthopyrans,<br>
comprise a reactive substituent. As used herein, the term "reactive substituent"<br>
means an arrangement of atoms, wherein a portion of the arrangement comprises a<br>
reactive moiety or residue thereof. According to various non-limiting embodiments<br>
disclosed herein, the reactive substituent further comprises a linking group<br>
connecting the reactive moiety to the photochromic naphthopyran. As used herein,<br>
the term "moiety" means a part or portion of an organic molecule that has a<br>
characteristic chemical property. As used herein, the term "reactive moiety" means<br>
a part or portion of an organic molecule that may react to form one or more covalent<br>
bonds with an intermediate in a polymerization reaction, or with a polymer into<br>
which it has been incorporated. As used herein, the phrase "intermediate in the<br>
polymerization reaction" means any combination of two or more host monomer<br>
VTN5080<br><br>
-23-<br>
units that are capable of reacting to form one or more bonds to additional host<br>
monomer unit(s) to continue a polymerization reaction or, alternatively, reacting<br>
with a reactive moiety of the reactive substituent on the photochromic material. For<br>
example, in one non-limiting embodiment the reactive moiety may react as a co-<br>
monomer in the polymerization reaction. Alternatively, but not limiting herein, the<br>
reactive moiety may react with the intermediate as a nucleophile or electrophile. As<br>
used herein, the term "host monomer or oligomer" means the monomeric or<br>
oligomeric material(s) into which the photochromic materials of the present<br>
disclosure may be incorporated. As used herein, the terms "oligomer" or<br>
"oligomeric material" refer to a combination of two or more monomer units that are<br>
capable of reacting with an additional monomer unit(s). As used herein, the term<br>
"linking group" means one or more group(s) or chain(s) of atoms that connect the<br>
reactive moiety to the photochromic naphthopyran. As used herein, the term<br>
"residue of a reactive moiety" means that which remains after a reactive moiety has<br>
been reacted with either a protecting group or an intermediate in a polymerization<br>
reaction. As used herein, the term "protecting group" means a group of atoms<br>
removably bonded to the reactive moiety that prevents the reactive moiety from<br>
participating in a reaction until the group is removed.<br>
[033] In one non-limiting embodiment, the reactive moiety comprises a<br>
polymerizable moiety. As used herein, the term "polymerizable moiety" means a<br>
part or portion of an organic molecule that can participate as a co-monomer in a<br>
polymerization reaction of a host monomer or oligomer. In another non-limiting<br>
embodiment, the reactive moiety comprises a nucleophilic moiety that reacts to form<br>
a bond with an electrophilic moiety on either the intermediate in the polymerization<br>
reaction or the host polymer. Alternatively, in another non-limiting embodiment,<br>
the reactive moiety comprises an electrophilic moiety that reacts to form a bond with<br>
a nucleophilic moiety on either the intermediate in the polymerization reaction or the<br>
host polymer. As used herein, the term "nucleophilic moiety" means an atom or<br>
grouping of atoms that is electron rich. As used herein, the term "electrophilic<br>
VTN5080<br><br>
-24-<br>
moiety" means an atom or grouping of atoms that is electron poor. It is appreciated<br>
by one skilled in the art that nucleophilic moieties can react with electrophilic<br>
moieties, for example to form a covalent bond therebetween.<br>
[034] As discussed above, in one non-limiting embodiment, the ophthalmic<br>
devices of the present invention compromise a photochromic naphthopyran and a<br>
reactive substituent bonded to the photochromic naphthopyran. The reactive<br>
substituent may be bonded to the photochromic naphthopyran at a variety of<br>
positions on the photochromic naphthopyran. Referring to the numbering scheme<br>
associated with structures 1, 2, 3, and 4 above, according to certain non-limiting<br>
embodiments, a reactive substituent(s) may be attached to the naphthopyran as<br>
follows. For structures 1 or 2, a reactive substituent may be bonded to the<br>
naphthopyran at any of the positions numbered 5 through 10. For structures 3 or 4, a<br>
reactive substituent may be bonded to the indeno-fused naphthopyran at any of the<br>
positions numbered 5 through 13. In addition, for structures 1, 2, 3, and 4, a reactive<br>
substituent may additionally or alternatively be bonded to group B and/or group B'.<br>
[035] For example, according to various non-limiting embodiments disclosed<br>
herein wherein the photochromic naphthopyran comprises a 2H-naphtho[l,2-<br>
b]pyran or a 3H-naphtho[2,l-b]pyran, structures 1 or 2 respectively, a reactive<br>
substituent may be bonded to the photochromic naphthopyran by replacing a<br>
hydrogen on the rings of the naphtho-portion of the photochromic naphthopyran<br>
with a reactive substituent. Alternatively or in addition, a reactive substituent may<br>
be bonded to photochromic naphthopyran 1 or 2 by replacing a hydrogen on the B<br>
and/or B' groups of the photochromic naphthopyran with a reactive substituent.<br>
According to other non-limiting embodiments, wherein the photochromic<br>
naphthopyran comprises an indeno[2',3':3,4] naphtho[l,2-b]pyran or an<br>
indeno[l',2':4,3 ]naphtho [2,l-b]pyran, structures 3 or 4 respectively, a reactive<br>
substituent may be bonded to the photochromic naphthopyran by replacing a<br>
hydrogen on the rings of the indeno-fused naphtho-portion of the photochromic<br>
naphthopyran with a reactive substituent. Alternatively or in addition, a reactive<br>
VTN5080<br><br>
-25-<br>
substituent may be bonded to photochromic naphthopyran 3 or 4 by replacing a<br>
hydrogen on the B and/or B' groups of the photochromic naphthopyran with a<br>
reactive substituent.<br>
[036] As discussed above, according to various non-limiting embodiments<br>
disclosed herein, the reactive substituent may be represented by one of the following<br>
groupings of structures:<br>
-A-D-E-G-J;<br>
-G-E-G-J;<br>
-D-E-G-J;<br>
-A-D-J;<br>
-D-G-J; and<br>
-D-J;<br>
wherein the groups -A-, -D-, -E-, and -G- are as set forth above, and -J is a group<br>
comprising a reactive moiety or residue of a reactive moiety; or -J is hydrogen,<br>
provided that if -J is hydrogen, -J is bonded to an oxygen of group -D- or -G-,<br>
forming a reactive moiety. The -J group may comprise any moiety capable of<br>
reacting with an intermediate in the polymerization reaction or the host monomer.<br>
For example, in one non-limiting embodiment, the -J group comprises a<br>
polymerizable moiety that can react as a co-monomer in an addition-type<br>
polymerization reaction or a condensation-type polymerization reaction of the host<br>
monomer, resulting in a co-polymer of the photochromic material and the host<br>
polymer. As used herein, the term "addition-type polymerization reaction" means a<br>
polymerization reaction in which the resultant polymer contains all of the atoms<br>
originally present in the monomer units. As used herein, the term "condensation-<br>
type polymerization reaction" means a polymerization reaction in which the<br>
resultant polymer does not contain all of the atoms originally present in the<br>
monomer units. As used herein, the term "host polymer" means the polymer that<br>
results from polymerization of the host monomer. For example, in certain non-<br>
limiting embodiments, the host polymer may include polymers that may contain a<br>
VTN5080<br><br>
-26-<br>
functionality that can react to form a bond with a reactive substituent on the<br>
photochromic material. In other non-limiting embodiments, the host polymer may<br>
be the polymer in which the photochromic material is incorporated within or<br>
otherwise co-polymerized with or bonded to. In another non-limiting embodiment,<br>
the -J group comprises a nucleophilic or electrophilic moiety that can react with an<br>
electrophilic or nucleophilic moiety, respectively, on an intermediate in the<br>
polymerization reaction or on the host polymer. In another non-limiting<br>
embodiment, -J comprises a hydrogen, provided that when -J is hydrogen, -J is<br>
bonded to an oxygen of group -D- or -G-, forming a reactive moiety, i.e., a hydroxyl<br>
group.<br>
[037] When -J is bonded to an oxygen or a nitrogen, reactive moieties suitable for<br>
use in various non-limiting embodiments of the present disclosure include, but are<br>
not limited to, acryl, methacryl, crotyl, 2-(methacryloxy)ethylcarbamyl, 2-<br>
(methacryloxy) ethoxycarbonyl, 4-vinylphenyl, vinyl, 1 -chlorovinyl, and epoxy.<br>
Structures corresponding to such reactive moieties are shown below:<br><br>
[038] Alternatively, -J may be hydrogen, provided that if -J is hydrogen, -J is<br>
bonded to an oxygen, such that the linkage is terminated by a reactive hydroxyl<br>
group, wherein the hydroxyl group comprises the reactive moiety.<br>
VTN5080<br><br>
-27-<br>
[039] As indicated above, the reactive substituent according to various non-<br>
limiting embodiments disclosed herein may comprise one or more groups -A-, -D-, -<br>
E-, and -G- which connect the group -J to the photochromic naphthopyran. As used<br>
herein, linking groups, as defined above, may comprise one or more of the groups<br>
-A-, -D-, -E-, and -G-. That is, various combinations of groups -A-, -D-, -E-, and -<br>
G- can form the linking group portion of the reactive substituent. As defined herein,<br>
the term "group" or "groups" means an arrangement of one or more atoms.<br>
[040] The structure of the linking groups of the various non-limiting embodiments<br>
will now be discussed in detail. As discussed above, the linking group portion of the<br>
reactive substituent comprises various combinations of the groups -A-, -D-, -E-, and<br>
-G-. For example, in certain non-limiting embodiments, the linking group portion of<br>
the reactive substituent comprises: -A-D-E-G-, -G-E-G-, -D-E-G-, -A-D-, -D-G-, or<br>
-D-, wherein a first group of the linking group is bonded to the photochromic<br>
naphthopyran at a position as set forth above and a second group of the linking<br>
group is bonded to the -J group as discussed in detail below. It will be understood<br>
by one having skill in the art that linking groups comprising various combinations of<br>
the groups -A-, -D-, -E-, and -G- can be synthesized by a variety of methods and the<br>
bond connections discussed below are for illustration purposes only and are in no<br>
way intended to imply a particular required or preferred synthetic approach to<br>
making the reactive substituent.<br>
[041] The connections between the various groups, i.e., -A-, -D-, -E-, and -G-,<br>
according to various non-limiting embodiments will now be discussed. In one non-<br>
limiting embodiment, the -A- group forms a bond with the photochromic<br>
naphthopyran and a bond with the -D- group. According to this non-limiting<br>
embodiment, the A-D bond may be a covalent bond between the carbonyl or<br>
methylene carbon of the -A- group and a nitrogen or oxygen of the diamine residue<br>
or amino alcohol residue of the -D- group. For example, according to various non-<br>
limiting embodiments, when -A- comprises a carbonyl carbon, the A-D bond may be<br>
an amide or an ester bond. In another non-limiting embodiment, when -A-<br>
VTN5080<br><br>
-28-<br>
comprises a methylene carbon, the A-D bond may be an amine or ether bond. As<br>
used herein, the term "methylene" means an organic group having the structure<br>
-CH2-.<br>
[042] In other non-limiting embodiments, the -D- group forms a bond with an -A-<br>
group (as described above) or the photochromic naphthopyran and a bond with an -<br>
E- or -G- group. According to one non-limiting embodiment, the D-E bond may be<br>
a covalent bond between a nitrogen or oxygen of the diamine residue or amino<br>
alcohol residue of the -D- group and the carbonyl carbon of one of the carboxylic<br>
acid residues of the -E- group, forming an amide or ester bond therebetween.<br>
According to another non-limiting embodiment, the D-G bond may be a covalent<br>
bond wherein the nitrogen or oxygen of the diamine residue or amino alcohol<br>
residue of the -D- group replaces a terminal oxygen residue on the polyol residue or<br>
polyalkyleneglycol residue of the -G- group, thereby forming an amine or ether<br>
bond.<br>
[043] In other non-limiting embodiments, the -E- group forms a bond with a -D-<br>
group (as described above) or a first -G- group and a bond with a second -G- group.<br>
According to these non-limiting embodiments, the E-G bond may be a covalent<br>
bond between a terminal oxygen residue on the polyol residue or polyalkyleneglycol<br>
residue of the -G- group and the carbonyl carbon of one of the carboxylic acid<br>
residues of the -E- group, forming an ester bond therebetween.<br>
[044] As previously discussed, the physical and chemical nature of linking groups<br>
may have an effect on the overall properties of the photochromic material. For<br>
example, in one non-limiting embodiment, the linking groups of the reactive<br>
substituent may have a hydrophilic nature such that the photochromic material may<br>
be more readily soluble in hydrophilic or polar host monomers. In another non-<br>
limiting embodiment, the linking groups of the reactive substituent may have a<br>
lipophilic nature such that the photochromic material may be more readily soluble in<br>
lipophilic or nonpolar host monomers.<br>
VTN5080<br><br>
-29-<br>
[045] The linking groups according to certain non-limiting embodiments of the<br>
present disclosure may also be of a uniform length and/or composition such that the<br>
resultant photochromic material may be more readily purified, when compared to a<br>
photochromic material having linking groups of non-uniform length. For example,<br>
in certain non-limiting embodiments where the linking group is of a uniform length<br>
and/or composition, the resultant photochromic material may be crystalline and<br>
therefore may be purified by recrystallization. In other non-limiting embodiments,<br>
where the linking group is of a uniform length and/or composition, the resultant<br>
photochromic material may be readily purified by chromatographic methods or other<br>
methods of purification known to one skilled in the art. For example, in one non-<br>
limiting embodiment set forth in Example 3, the photochromic material (i.e., 3-<br>
phenyl-3-(4-morpholinophenyl)-6-methoxy-7-(4-(2-<br>
methacryloxyethyl)carbamylpiperizin-1 -yl)-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran) comprises a photochromic naphthopyran with<br>
a reactive substituent corresponding to -D-J. According to this non-limiting<br>
embodiment, the photochromic material may be purified by crystallization with an<br>
ethyl acetate/hexanes mixture to yield purple-tinted crystals. In another non-limiting<br>
embodiment set forth in Example 5, the photochromic material (i.e., 3-phenyl-3-(4-<br>
(4-(2-methacryloxyethyl)carbamylpiperazin-1 -yl)phenyl)-6,11 -dimethoxy-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran) comprises a photochromic<br>
naphthopyran with a reactive substituent corresponding to -D-J. According to this<br>
non-limiting embodiment, the photochromic material may be purified by silica gel<br>
chromatography to yield a green expanded foam solid. In other non-limiting<br>
embodiments, an intermediate in the synthesis of the photochromic material may be<br>
readily purified by recrystallization methods, chromatographic methods or other<br>
methods of purification know to one skilled in the art.<br>
[046] Bonding between the various linking group(s) and the group -J will now be<br>
discussed. According to various non-limiting embodiments disclosed herein, the<br>
group -J may be bonded to the linking group by a G-J bond or a D-J bond. In certain<br>
VTN5080<br><br>
-30-<br>
non-limiting embodiments where the reactive moiety -J is bonded to the linking<br>
group by a G-J bond, the G-J bond may have many possible structures. For<br>
example, when -J is acryl, methacryl, or crotyl, the G-J bond may be an ester bond,<br>
that is, a terminal oxygen residue of the -G- group bonds with the carbonyl of the -J<br>
group. Alternatively, when -J is 2-(methacryloxy)ethylcarbamyl or 2-<br>
(methacryloxy)ethoxycarbonyl, the G-J bond may be a carbamate and carbonate<br>
bond, respectively, where a terminal oxygen residue of the -G- group bonds with the<br>
carbonyl of the ethyl carbamyl or ethoxycarbonyl portion of the -J group. Further,<br>
when -J is 4-vinylphenyl, vinyl, 1-chlorovinyl or epoxy, the G-J bond may be an<br>
ether bond between a terminal oxygen residue of the -G- group and the carbon of the<br>
-J group. In certain non-limiting embodiments, the -J group may be a hydrogen,<br>
such that the G-J bond is an oxygen-hydrogen bond resulting in a reactive moiety,<br>
i.e., a hydroxyl group, on the linking group.<br>
[047] In other non-limiting embodiments where the reactive moiety -J is bonded to<br>
the linking group by a D-J bond, the D-J bond may have many possible structures.<br>
For example, when -J is acryl, methacryl, or crotyl, the D-J bond may be an ester or<br>
amide bond, that is, an alcohol oxygen or an amine nitrogen on the amino alcohol<br>
residue or diamine residue of the -D- group bonds with the carbonyl of the -J group.<br>
Alternatively, when -J is 2-(methacryloxy)ethylcarbamyl or 2-<br>
(methacryloxy)ethoxycarbonyl, the D-J bond may be a urea, carbamate, or carbonate<br>
bond, where an amine nitrogen on the diamine residue or amino alcohol residue, or<br>
an alcohol oxygen on the amino alcohol residue of the -D- group bonds with the<br>
carbonyl of the ethylcarbamyl or ethoxycarbonyl portion of the -J- group. Further,<br>
when -J is 4-vinylphenyl, vinyl, 1-chlorovinyl or epoxy, the D-J may be an amine or<br>
ether bond between an amine nitrogen or the alcohol oxygen, respectively, of the -D-<br>
group and the carbon of the -J group. In certain non-limiting embodiments, when -<br>
D- is an amino alcohol, the - J group may be a hydrogen bonded to the oxygen of the<br>
amino alcohol residue, such that the D-J bond is an oxygen-hydrogen bond, resulting<br>
in a reactive moiety, i.e., a hydroxyl group, on the linking group.<br>
VTN5080<br><br>
-31-<br>
[048] According to various non-limiting embodiments disclosed herein, wherein -J<br>
is acryl, methacryl, 2-(methacryloxy)ethylcarbamyl or epoxy, -J may be attached to<br>
the -D- or -G- group of the linking group by condensation of-D- or -G- with<br>
acryloyl chloride, methacryloyl chloride, 2-isocyanatoethyl methacrylate or<br>
epichlorohydrin, respectively.<br>
[049] Another non-limiting embodiment provides a photochromic material<br>
represented by:<br>
[050] PC-[R]r<br>
wherein: (a) PC comprises a photochromic naphthopyran, which may be for<br>
example, without limitation, a 2H-naphtho[l,2-b]pyran, a 3H-naphtho[2,l-b]pyran,<br>
an indeno[2',3':3,4]naphtho[l,2-b]pyran, an indeno[l',2':4,3]naphtho[2,l-b]pyran,<br>
or a mixture thereof; (b) r is an integer ranging from 1 to 4; and (c) R is a reactive<br>
substituent represented by one of:<br>
-A-D-E-G-J;<br>
-G-E-G-J;<br>
-D-E-G-J;<br>
-A-D-J;<br>
-D-G-J; and<br>
-D-J;<br>
wherein the groups -A-, -D-, -E-, and -G- are as set forth above, and-J is a group<br>
comprising a reactive moiety or residue thereof; or -J is hydrogen, provided that if -J<br>
is hydrogen, -J is bonded to an oxygen of group -D- or -G-, forming a reactive<br>
moiety. Non-limiting examples of -J, according to certain non-limiting<br>
embodiments include acryl, crotyl, methacryl, 2-(methacryloxy)ethylcarbamyl, 2-<br>
(methacryloxy)ethoxycarbonyl, 4-vinylphenyl, vinyl, 1-chlorovinyl, and epoxy.<br>
[051] As discussed with respect to the various non-limiting embodiments set forth<br>
above, the reactive substituent R according to this non-limiting embodiment may be<br>
bonded to the photochromic naphthopyran PC in a variety of positions. For<br>
example, when PC is a 2H-naphtho[l,2-b]pyran or a 3H-naphtho[2,l-b]pyran, a<br>
VTN5080<br><br>
-32-<br>
reactive substituent R may be bonded at any of the positions numbered 5 through 10<br>
according to structures 1 or 2 above. When PC is an indeno[2',3':3,4]naphtho[l,2-<br>
b]pyran or an indeno[l',2':4,3] naphtho[2,l-b]pyran, a reactive substituent R may be<br>
bonded at any of the positions numbered 5 through 13 according to structures 3 or 4<br>
above. In addition or alternatively, when PC is a 2H-naphtho[l,2-b]pyran, a 3H-<br>
naphtho[2,l-b]pyran naphthopyran, an indeno[2',3':3,4]naphtho [l,2-b]pyran or an<br>
indeno[l',2':4,3]riaphtho[2,l-b]pyran, a reactive substituent R may be bonded to<br>
group B and/or group B'.<br>
[052] Further, as indicated above, the photochromic materials according to various<br>
non-limiting embodiments disclosed herein may comprises one reactive substituent<br>
R or may comprise multiple reactive substituents R, each of which may be the same<br>
or different. For example, according to one non-limiting embodiment wherein r is 2,<br>
the photochromic materials comprise two reactive substituents R, which may be the<br>
same or different, and which may be bonded to the photochromic naphthopyran PC<br>
at two of the numbered positions set forth above, at one of the numbered positions<br>
and on one of the B or B' groups, or both R substituents may be bonded to the<br>
photochromic naphthopyran PC at the B and/or B' group.<br>
[053] According to still other non-limiting embodiments disclosed herein, the<br>
photochromic material comprising at least one reactive substituent can be<br>
represented by the following structures I through IV, or a mixture thereof:<br>
VTN5080<br><br>
-33-<br><br>
[054] Referring to structure II above, according to various non-limiting<br>
embodiments of the present disclosure, non-limiting examples for the structure of<br>
group R1 include: the reactive substituent R; hydrogen, hydroxy, C1-C3 alkyl; and<br>
the group, -C(=0)W, wherein W is -OR7, -N(R8)R9, piperidino or morpholino,<br>
wherein R7 is allyl, C1-C6 alkyl, phenyl, mono(C1-C6)alkyl substituted phenyl,<br>
mono(C1-C6)alkoxy substituted phenyl, phenyl(C1-C3)alkyl, mono(C1-C6)alkyl<br>
substituted phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-C3)alkyl,<br>
C1-C6 alkoxy(C2-C4)alkyl or C1-C6 haloalkyl, Rg and R9 are each independently<br>
chosen from C1-C6 alkyl, C5-C7 cycloalkyl, phenyl, mono-substituted phenyl, and di-<br>
substituted phenyl, said phenyl substituents are C1-C6 alkyl or C1-C6 alkoxy, and<br>
said halo substituent are chloro or fluoro.<br>
VTN5080<br><br>
-34-<br>
[055] Referring now to structure I above, according to various non-limiting<br>
embodiments of the present disclosure, non-limiting examples for the structure of<br>
group R1' include: the reactive substituent R; hydrogen; hydroxy; C1-C3 alkyl; and<br>
the group -C(=O)W, wherein W is -OR7, -N(R8)R9, piperidino or morpholino,<br>
wherein R7 is allyl, C1-C6 alkyl, phenyl, mono(C1-C6)alkyl substituted phenyl,<br>
mono(C1-C6)alkoxy substituted phenyl, phenyl(C1-C3)alkyl, mono(C1-C6)alkyl<br>
substituted phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-C3)alkyl,<br>
C1-C6 alkoxy(C2-C4)alkyl or C1-C6 haloalkyl, and R8 and R9 are each independently<br>
chosen from C1-C6 alkyl, C5-C7 cycloalkyl, phenyl, mono-substituted phenyl, and di-<br>
substituted phenyl, wherein said phenyl substituents are C1-C6 alkyl or C1-C6<br>
alkoxy, and said halo substituent are chloro or fluoro.<br>
[056] Referring now to structures I and II above, according to various non-limiting<br>
embodiments of the present disclosure, non-limiting examples for the structure of<br>
group R2 include: the reactive substituent R; hydrogen; C1-C6 alkyl; C3-C7<br>
cycloalkyl; substituted or unsubstituted phenyl; and -OR10; or -OC(=O)R|0, wherein<br>
Rio is hydrogen, C1-C6 alkyl, phenyl(C1-C3)alkyl, mono(C1-C6)alkyl substituted<br>
phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-C3)alkyl, (C1-<br>
C6)alkoxy(C2-C4)alkyl, C3-C7 cycloalkyl, or mono(C1-C4)alkyl substituted C3-C7<br>
cycloalkyl, and said phenyl substituents are C1-C6 alkyl or C1-C6 alkoxy.<br>
[057] Referring now to structures I, II, III, and IV above, in various non-limiting<br>
embodiments of the present disclosure, non-limiting examples of structures for each<br>
R3 and each R4 independently include: the reactive substituent R; hydrogen; fluoro;<br>
chloro; C1-C6 alkyl; C3-C7 cycloalkyl; substituted or unsubstituted phenyl; -OR10; or<br>
-OC(=0)Rio, wherein R10 is hydrogen, C1-C6 alkyl, phenyl(C1-C3)alkyl, mono(C1-<br>
C6)alkyl substituted phenyl(C]-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-<br>
C3)alkyl, (C1-C6)alkoxy(C2-C4)alkyl, C3-C7 cycloalkyl, or mono(C1-C4)alkyl<br>
substituted C3-C7 cycloalkyl, and said phenyl substituents are C1-C6 alkyl or C1-C6<br>
alkoxy; and a mono-substituted phenyl, said phenyl having a substituent located at<br>
the para position, wherein the substituent is: a dicarboxylic acid residue or<br>
VTN5080<br><br>
-35-<br>
derivative thereof, a diamine residue or derivative thereof, a amino alcohol residue<br>
or derivative thereof, a polyol residue or derivative thereof, -CH2-, -(CH2)t-, or -[O-<br>
(CH2)t]k-, wherein t is an integer 2, 3, 4, 5, or 6 and k is an integer from 1 to 50, the<br>
substituent being connected to an aryl group on another photochromic material. For<br>
structures I, II, III, and IV, n is an integer from 1 to 4.<br>
[058] Other non-limiting examples of structures for each R3 and each R4 include a<br>
nitrogen containing group, wherein the nitrogen containing group may be<br>
-N(R11)R12, wherein R11 and R12 are each independently hydrogen, C1-C8 alkyl,<br>
phenyl, naphthyl, furanyl, benzofuran-2-yl, benzofuran-3-yl, thienyl, benzothien-2-<br>
yl, benzothien-3-yl, dibenzofuranyl, dibenzothienyl, benzopyridyl, fluorenyl, Ci-Cg<br>
alkylaryl, C3-C20 cycloalkyl, C4-C20 bicycloalkyl, C5-C20 tricycloalkyl or C1-C20<br>
alkoxyalkyl, wherein said aryl group is phenyl or naphthyl, or R11 and R12 come<br>
together with the nitrogen atom to form a C3-C20 hetero-bicycloalkyl ring or a C4-C20<br>
hetero-tricycloalkyl ring; a nitrogen containing ring represented by the following<br>
graphic formula VA: <br>
wherein each Y is independently for each occurrence -CH2-, -CH(R13)-, -C(R13)2-, -<br>
CH(aryl)-, -C(aryl)2-, or -C(R13)(aryl)-, and Z is -Y-, -O-, -S-, -S(O)-, -SO2-, -NH-, -<br>
N(R13)-, or -N(aryl)-, wherein each R13 is independently C1-C6 alkyl, each aryl is<br>
independently phenyl or naphthyl, m is an integer 1, 2 or 3, and p is an integer 0, 1,2,<br>
or 3 and when p is 0, Z is Y; a group represented by one of the following graphic<br>
formulae VB or VC:<br>
VTN5080<br><br>
-36-<br><br>
wherein R15, R16, and R17 are each independently hydrogen, C1-C6 alkyl, phenyl, or<br>
naphthyl, or R15 and R16 together may form a ring of 5 to 8 carbon atoms and each<br>
R14 is independently for each occurrence C1-C6 alkyl, C1-C6 alkoxy, fluoro or chloro<br>
and p is an integer 0, 1, 2, or 3; unsubstituted, mono-, or di-substituted C4-C18<br>
spirobicyclic amine; and unsubstituted, mono-, or di-substituted C4-C18 spirotricyclic<br>
amine; wherein said spirobicyclic and spirotricyclic amine substituents are<br>
independently for each occurrence aryl, C1-C6 alkyl, C1-C6 alkoxy, or phenyl(C1-<br>
C6)alkyl.<br>
[059] Alternatively, according to various non-limiting embodiments disclosed<br>
herein, an R3 group in the 6-position and an R3 group in the 7-position, according to<br>
the numbering set forth in structures 1, 2, 3, and 4 above, together form a group<br>
represented by graphic formulae VD or VE:<br><br>
wherein T and T are each independently oxygen or the group -NR11-, where R11,<br>
R15, and R16 are as set forth above.<br>
[060] Referring now to structures III and IV above, according to various non-<br>
limiting embodiments of the present disclosure, non-limiting examples of the<br>
structure for each of groups R5 and R6 may independently include: the reactive<br>
substituent R; hydrogen; hydroxy; C1-C6 alkyl; C3-C7 cycloalkyl; allyl; phenyl;<br>
mono-substituted phenyl; benzyl; mono-substituted benzyl; chloro; fluoro; the group<br>
-C(=O)W, wherein W is hydroxy, C1-C6 alkyl, C1-C6 alkoxy, phenyl, mono-<br>
VTN5080<br><br>
-37-<br>
substituted phenyl, amino, mono(C1-C6)alkylamino, or di(C1-C6)alkylamino; -OR18,<br>
wherein R18 is C1-C6 alkyl, phenyl(C1-C3)alkyl, mono(C1-C6)alkyl substituted<br>
phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-C3)alkyl, C1-C6<br>
alkoxy(C2-C4)alkyl, C3-C7 cycloalkyl, mono(C1-C4)alkyl substituted C3-C7<br>
cycloalkyl, C1-C6 chloroalkyl, C1-C6 fluoroalkyl, allyl, or the group, -CH(R19)Y',<br>
wherein R19 is hydrogen or C1-C3 alkyl and Y' is CN, CF3, or COOR20, wherein R20<br>
is hydrogen or C1-C3 alkyl, or R18 is the group, -C(=O)W", wherein W" is<br>
hydrogen, C1-C6 alkyl, C1-C6 alkoxy, the unsubstituted, mono-, or di-substituted aryl<br>
groups phenyl or naphthyl, phenoxy, mono- or di-(C1-C6)alkyl substituted phenoxy,<br>
mono- or di-(C|-C6)alkoxy substituted phenoxy, amino, mono(C1-C6)alkylamino,<br>
di(C1-C6)alkylamino, phenylamino, mono- or di-(C1-C6)alkyl substituted<br>
phenylamino, or mono- or di-( C1-C6)alkoxy substituted phenylamino, wherein each<br>
of said phenyl, benzyl or aryl group substituents are independently C1-C6 alkyl or<br>
C1-C6 alkoxy; and a mono-substituted phenyl, said phenyl having a substituent<br>
located at the para position, wherein the substituent is: a dicarboxylic acid residue<br>
or derivative thereof, a diamine residue or derivative thereof, a amino alcohol<br>
residue or derivative thereof, a polyol residue or derivative thereof, -CH2-, -(CH2)r,<br>
or -[O-(CH2)t]k-, wherein t is an integer 2, 3, 4, 5 or 6 and k is an integer from 1 to<br>
50, the substituent being connected to an aryl group on another photochromic<br>
material.<br>
[061] Alternatively, in certain non-limiting embodiments, R5 and R6 can together<br>
form an oxo group, a spiro-carbocyclic group containing 3 to 6 carbon atoms, or a<br>
spiro-heterocyclic group containing 1 to 2 oxygen atoms and 3 to 6 carbon atoms<br>
including the spirocarbon atom, said spiro-carbocyclic and spiro-heterocyclic groups<br>
being annellated with 0, 1 or 2 benzene rings.<br>
[062] Referring again to structures I, II, III, and IV above, according to various<br>
non-limiting embodiments, non-limiting examples of the structure of the groups B<br>
and B' may each independently include: a substituted phenyl; a substituted aryl; a<br>
substituted 9-julolindinyl; a substituted heteroaromatic group, such as pyridyl<br>
VTN5080<br><br>
-38-<br>
furanyl, benzofuran-2-yl, benzofuran-3-yl, thienyl, benzothien-2-yl, benzothien-3-yl,<br>
dibenzofuranyl, dibenzothienyl, carbazoyl, benzopyridyl, indolinyl, or fluorenyl,<br>
wherein one or more phenyl, aryl, 9-julolindinyl, or heteroaromatic substituent is the<br>
reactive substituent R; an unsubstituted, mono-, di-, or tri-substituted phenyl or aryl<br>
group; 9-julolidinyl; or an unsubstituted, mono- or di-substituted heteroaromatic<br>
group; such as pyridyl, furanyl, benzofuran-2-yl, benzofuran-3-yl, thienyl,<br>
benzothien-2-yl, benzothien-3-yl, dibenzofuranyl, dibenzothienyl, carbazoyl,<br>
benzopyridyl, indolinyl or fluorenyl, wherein each of the phenyl, aryl and<br>
heteroaromatic substituents are independently chosen from: hydroxyl, a group -<br>
C(=O)R21, wherein R21 is -OR22, -N(R23)R24, piperidino, or morpholino, wherein R22<br>
is allyl, C1-C6 alkyl, phenyl, mono(C1-C6)alkyl substituted phenyl, mono(C1-<br>
C6)alkoxy substituted phenyl, phenyl(C1-C3)alkyl, mono(C1-C6)alkyl substituted<br>
phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-C3)alkyl, C1-C6<br>
alkoxy(C2-C4)alkyl or C1-C6 haloalkyl, and R23 and R24 are each independently C1-<br>
C6 alkyl, C5-C7 cycloalkyl, phenyl or substituted phenyl, wherein the phenyl<br>
substituents are C1-C6 alkyl or C1-C6 alkoxy, and said halo substituent are chloro or<br>
fluoro, and aryl, mono(C1-C12)alkoxyaryl, di(C1-C12)alkoxyaryl, mono(C1-<br>
C12)alkylaryl, di(C1-C12)alkylaryl, haloaryl, C3-C7 cycloalkylaryl, C3-C7 cycloalkyl,<br>
C3-C7 cycloalkyloxy, C3-C7 cycloalkyloxy(C1-C12)alkyl, C3-C7 cycloalkyloxy(C1-<br>
C12)alkoxy, aryl(C1-C12)alkyl, aryl(C1-C12)alkoxy, aryloxy, aryloxy(C1-C12)alkyl,<br>
aryloxy(C1-C12)alkoxy, mono- or di(C1-C12)alkylaryl(C1-C12)alkyl, mono- or di-(d-<br>
C12)alkoxyaryl(C1-C12)alkyl, mono- or di-(C1-C12)alkylaryl(C|-C12)alkoxy, mono- or<br>
di-(C1-C12)alkoxyaryl(C1-C12)alkoxy, amino, mono- or di-(C1-C12)alkylamino,<br>
diarylamino, piperazino, N-(C1-C12)alkylpiperazino, N-arylpiperazino, aziridino,<br>
indolino, piperidino, morpholino, thiomorpholino, tetrahydroquinolino,<br>
tetrahydroisoquinolino, pyrrolidyl, C1-C12 alkyl, C1-C12 haloalkyl, C1-C12 alkoxy,<br>
mono(C1-C12 )alkoxy(C1-C12 )alkyl, acryloxy, methacryloxy, and halogen; an<br>
unsubstituted or mono-substituted group, such as pyrazolyl, imidazolyl, pyrazolinyl,<br>
imidazolinyl, pyrrolinyl, phenothiazinyl, phenoxazinyl, phenazinyl, or acridinyl,<br>
VTN5080<br><br>
-39-<br>
wherein each of said substituents are independently C1-C12 alkyl, C1-C12 alkoxy,<br>
phenyl, or halogen; a mono-substituted phenyl, said phenyl having a substituent<br>
located at the para position, wherein the substituent is: a dicarboxylic acid residue<br>
or derivative thereof, a diamine residue or derivative thereof, an amino alcohol<br>
residue or derivative thereof, a polyol residue or derivative thereof, -CH2-, -(CH2)t-,<br>
or -[O-(CH2)t]k-, wherein t is an integer 2, 3, 4, 5, or 6 and k is an integer from 1 to<br>
50, the substituent being connected to an aryl group on another photochromic<br>
material; a group represented by one of:<br><br>
wherein K is -CH2- or -O-, and M is -O- or substituted nitrogen, provided that when<br>
M is substituted nitrogen, K is -CH2-, the substituted nitrogen substituents are<br>
hydrogen, C1-C12 alkyl, or C1-C12 acyl, each R25 is independently for each<br>
occurrence C1-C12 alkyl, C1-C12 alkoxy, hydroxy, or halogen, R26 and R27 each are<br>
independently hydrogen or C1-C12 alkyl; and u is the integer 0, 1, or 2; or a group<br>
represented by: <br>
wherein R28 is hydrogen or C1-C12 alkyl, and R29 is an unsubstituted, mono-, or di-<br>
substituted group, such as naphthyl, phenyl, furanyl, or thienyl, wherein the<br>
substituents are independently C1-C12 alkyl, C1-C12 alkoxy, or halogen.<br>
[063] Alternatively according to certain non-limiting embodiments, B and B' taken<br>
together form un unsubstituted mono-, or di-substituted fluoren-9-ylidene, each of<br>
said fluoren-9-ylidene substituents are independently C1-C12 alkyl, C1-C12 alkoxy, or<br>
halogen.<br>
VTN5080<br><br>
-40-<br>
[064] For each of the groups R1, R1', R2, R3, R4, R5, R6, B, and B' discussed above,<br>
wherein the group comprises the reactive substituent R, each reactive substituent R<br>
can be independently chosen from and represented by one of:<br>
-A-D-E-G-J;<br>
-G-E-G-J;<br>
-D-E-G-J;<br>
-A-D-J;<br>
-D-G-J; and<br>
-D-J.<br>
[065] Non-limiting examples of structures for -A- according to various non-<br>
limiting embodiments of the present disclosure include -C(=O)-, -OC(=O)-, -<br>
NHC(=O)-, and -CH2-.<br>
[066] Non-limiting examples of structures for -D- according to various non-<br>
limiting embodiments of the present disclosure include diamine residues or<br>
derivatives thereof, and amino alcohol residues or derivatives thereof as set forth<br>
above.<br>
[067] In certain non-limiting embodiments where -D- is a diamine residue or a<br>
derivative thereof, a first amine nitrogen of the diamine residue may form a bond<br>
with -A-, structure I, structure II, structure III, or structure IV, and a second amine<br>
nitrogen of the diamine residue may form a bond with -E-, -G-, or -J. In other non-<br>
limiting embodiments where -D- is a amino alcohol residue or a derivative thereof,<br>
the amine nitrogen of the amino alcohol residue may form a bond with -A-, structure<br>
I, structure II, structure III, or structure IV, and the alcohol oxygen of the amino<br>
alcohol residue may form a bond with -E-, -G-, or -J; or the amine nitrogen of said<br>
amino alcohol residue may form a bond with -E-, -G-, or -J, and said alcohol oxygen<br>
of said amino alcohol residue may form a bond with -A-, structure I, structure II,<br>
structure III, or structure IV.<br>
[068] Non-limiting examples of structures for -E- according to various non-<br>
limiting embodiments of the present disclosure include dicarboxylic acid residues or<br>
VTN5080<br><br>
-41-<br>
derivatives thereof, as set forth above. In certain non-limiting embodiments of -E-, a<br>
first carbonyl group of said dicarboxylic acid residue may form a bond with -G- or -<br>
D-, and a second carbonyl group of said dicarboxylic acid residue may form a bond<br>
with -G-.<br>
[069] Non-limiting examples of structures for -G- according to various non-<br>
limiting embodiments of the present disclosure include polyalkyleneglycol residues<br>
and polyol residues and derivatives thereof, as set forth above. In certain non-<br>
limiting embodiments where -G- a polyalkyleneglycol residue, non-limiting<br>
examples of said polyalkyleneglycol include the structure:<br>
-[(OC2H4)x(OC3H6)y(OC4H8)z]-O-,<br>
wherein x, y, and z are each a number between 0 and 50, and the sum of x, y, and z<br>
is from 1 to 50. In other non-limiting embodiments where -G- is a polyol residue or<br>
derivative thereof, a first polyol oxygen of the polyol residue may form a bond with<br>
-E-, -D-, structure I, structure II, structure III, or structure IV, and a second polyol<br>
oxygen of the polyol may form a bond with -E- or -J.<br>
[070] According to various non-limiting embodiments of the present disclosure, -J<br>
comprises the reactive moiety or residue thereof; or alternatively, -J is hydrogen,<br>
provided that if -J is hydrogen, -J is bonded to an oxygen of group -D- or -G-,<br>
forming a reactive moiety. Non-limiting embodiments of reactive moieties are<br>
discussed above.<br>
[071] Further, according to various non-limiting embodiments disclosed herein,<br>
one of groups R1, R1', R2, R3, R4, R5, R6, B, and B' on each of structures I, II, III,<br>
and IV comprises a reactive substituent R. In another non-limiting embodiment, two<br>
of the groups R1, R1', R2, R3, R4, R5, R6, B, and B' on each of structures I, II, III, and<br>
IV may comprise a reactive substituent R, wherein the reactive substituents R may<br>
be the same or different. In yet another non-limiting embodiment, from 1 and 4 of<br>
the groups R1, R1', R2, R3, R4, R5, R6, B, and B' on each of structures I, II, III, and<br>
IV may comprise a reactive substituent R, wherein the reactive substituents R may<br>
be the same or different.<br>
VTN5080<br><br>
-42-<br>
[072] Non-limiting examples of photochromic materials comprising naphthopyrans<br>
comprising a reactive substituent R according to the various embodiments of the<br>
present disclosure include the following:<br>
(i) 3,3-di(4-methoxyphenyl)-6-methoxy-7-(3-(2-<br>
methacryloxyethyl)carbamyloxy methylenepiperidin-1 -yl)-<br>
13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-<br>
b]pyran;<br>
(ii) 3 -phenyl-3 -(4-morpholinophenyl)-6-methoxy-7-(3 -(2-<br>
methacryloxyethyl) carbamyloxymethylenepiperidin-1 -yl)-<br>
13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-<br>
b]pyran;<br>
(iii) 3-phenyl-3-(4-(4-phenylpiperazino)phenyl)-6-methoxy-7-(4-<br>
(2-methacryloxyethyl)carbamyloxypiperidin-1 -yl)-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho[1,2-b]pyran;<br>
(iv) 3-(4-fluorophenyl)-3-(4-methoxyphenyl)-6-methoxy-7-(4-(2-<br>
methacryloxyethyl) carbamyloxypiperidin-1 -yl)-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho [1,2-b]pyran;<br>
(v) 3-(4-fluorophenyl)-3-(4-morpholinophenyl)-6-methoxy-7-(4-<br>
(2-methacryloxyethyl)carbamyloxypiperidin-1-yl)-13,13 -<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(vi) 3-phenyl-3-(4-morpholinophenyl)-6-methoxy-7-(4-(2-<br>
methacryloxyethyl) carbamyloxypiperidin-1 -yl)-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho [1,2-b]pyran;<br>
(vii) 3-phenyl-3-(4-morpholinophenyl)-6-methoxy-7-(4-(2-<br>
methacryloxyethyl) carbamylpiperazin-1 -yl)-13,13-dimethyl-<br>
3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(viii) 3-phenyl-3-(4-(2-(2-<br>
methacryloxyethyl)carbamyloxyethoxy)phenyl)-6-methoxy-7-<br>
VTN5080<br><br>
VTN5080<br><br>
-43-<br>
piperidino-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(ix) 3-phenyl-3-(4-methoxyphenyl)-6-methoxy-7-(4-(2-<br>
methacryloxyethyl) carbamylpiperazin-1 -yl)-13,13 -dimethyl-<br>
3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(x) 3-phenyl-3-(4-(2-(2-<br>
methacryloxyethyl)carbamyloxyethoxy)phenyl)-6,7-<br>
dimethoxy-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(xi) 3-phenyl-3-(4-(4-(2-methacryloxyethyl)carbamylpiperazin-1 -<br>
yl)phenyl)-6,11 -dimethoxy-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(xii) 3-phenyl-3-(4-(2-methacryloxyethyl)carbamyloxyphenyl)-<br>
6,7-dimethoxy-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(xiii) 3-phenyl-3-(4-morpholinophenyl)-6-methoxy-7-(3-(2-(2-(2-<br>
(2-(2-(2-(2-<br>
methacryloxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ca<br>
rbonylethyl) carboxymethylenepiperidin-1 -yl)-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(xiv) 3-phenyl-3-(4-methoxyphenyl)-6-methoxy-7-(3-(2-(2-(2-(2-<br>
(2-(2-(2-<br>
methacryloxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ca<br>
rbonylethyl) carboxymethylenepiperidin-1 -yl)-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(xv) 3-phenyl-3-(4-morpholinophenyl)-6-methoxy-7-(4-(2-(2-(2-<br>
(2-(2-(2-(2-<br>
methacryloxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ca<br><br>
-44-<br>
rbonylethyl) carboxypiperidin-1-yl)-13,13-dimethyl-3H, 13H-<br>
indeno [2' ,3': 3,4] naphtho [ 1,2-b]pyran;<br>
(xvi) 3-phenyl-3-(4-methoxyphenyl)-6-methoxy-7-(4-(2-(2-(2-(2-<br>
(2-(2-(2-<br>
methacryloxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ca<br>
rbonylethyl) carboxypiperidin-1 -yl)-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(xvii) 3-phenyl-3-(4-(2-(2-(2-(2-(2-(2-(2-(2-<br>
methacryloxyethoxy)ethoxy)ethoxy)ethoxy)<br>
ethoxy)ethoxy)carbonylethyl)carboxyethoxy)phenyl)-6-<br>
methoxy-7-morpholino-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(xviii) 3-phenyl-3-(4-(4-(2-(2-<br>
methacryloxyethyl)carbamyloxyethyl)piperazin-1 -yl)phenyl)-<br>
13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-<br>
bjpyran;<br>
and mixtures thereof.<br>
[073] Non-limiting methods of synthesizing the reactive substituent R on the<br>
photochromic napthopyran according to various non-limiting embodiments of the<br>
photochromic materials comprising a reactive substituent disclosed herein will now<br>
be discussed with reference to the reaction schemes presented in Figures 1 and 2.<br>
Figure 1 depicts various non-limiting methods of synthesizing a reactive substituent<br>
R at the 7 position of an indeno[2',3':3,4] naphtho[l,2-b]pyran. Figure 2 depicts<br>
one non-limiting method of synthesizing a reactive substituent R on a B group of an<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran. One skilled in the art will appreciate that<br>
there may be multiple ways to synthesize the reactive substituent on the<br>
photochromic naphthopyran, therefore it will be appreciated that these reaction<br>
schemes are presented for illustration purposes only and are not intended to be<br>
limiting herein.<br>
VTN5080<br><br>
-45-<br>
[074] Referring now to Figure 1, 2,3-dimethoxy-7,7-dimethyl-7H-<br>
benzo[C]fluoren-5-ol 5 may be reacted with a substituted 2-propyn-1-ol to form<br>
indeno[2',3':3,4] naphtho[l,2-b]pyran 6. Non-limiting methods of synthesizing 7H-<br>
benzo[C]fluoren-5-ols, suitable for use in the synthesis of various non-limiting<br>
embodiments disclosed herein, are described in U.S. Patent No. 6,296,785 at col. 11,<br>
lines 6 to col. 28, line 35, the disclosure of which is incorporated herein by<br>
reference. Non-limiting methods of synthesizing substituted 2-propyn-1-ols,<br>
suitable for use in the synthesis of various non-limiting embodiments disclosed<br>
herein, are described in U.S. Patent Nos. 5,458,814, col. 4, line 11 to col. 5, line 9,<br>
and at step 1 of Examples 1,4-6, 11,12, and 13, and 5,645,767 at col. 5, line 12 to<br>
col. 6, line 30, the disclosures of which are incorporated herein by reference.<br>
Indeno-fused naphthopyran 6 may then be reacted with a diamine or amino alcohol.<br>
For example, 6 may be reacted with a diamine, such as piperazine to afford the 6-<br>
methoxy-7-(piperizin-1 -yl)-13,13-dimethyl-3H, 13H-indeno[2' ,3':3,4] naphtho[ 1,2-<br>
b]pyran 7. The piperazine moiety of 7 may be condensed with 2-iscyanatoethyl<br>
methacrylate to afford photochromic naphthopyran 8 having an R substituent<br>
comprising -D-J, as defined herein above, where -D- is a diamine residue.<br>
Alternatively, indeno-fused naphthopyran 6 may be reacted with an amino alcohol,<br>
such as 3-piperidinomethanol to afford the 6-methoxy-7-(3-<br>
hydroxymethylenepiperidin-1-yl)-13,13-dimethyl-3H,13H-indeno[2',3':3,4]<br>
naphtho[l,2-b]pyran 9. The hydroxy moiety of 9 may be condensed with 2-<br>
iscyanatoethyl methacrylate to afford photochromic naphthopyran 10 having an R<br>
substituent comprising -D-J, as defined herein above, where -D- is an amino alcohol<br>
residue.<br>
[075] Referring still to Figure 1, the hydroxy moiety of 9 may alternatively be<br>
reacted with a cyclic anhydride, such as succinic anhydride to afford the 6-methoxy-<br>
7-(3-(2-hydroxycarbonylethylcarboxymethylenepiperidin-1 -yl)-13,13-dimethyl -<br>
3H,13H-indeno[2',3':3,4] naphtho[l,2-b]pyran 11. The carboxylic acid of 11 may<br>
be esterified with polyethyleneglycol methacrylate of afford photochromic<br>
VTN5080<br><br>
-46-<br>
naphthopyran 12 having an R substituent comprising -D-E-G-J, as defined herein<br>
above.<br>
[076] Referring now to Figure 2, 7,7-dimethyl-7H-benzo[C]fluoren-5-ol (13) may<br>
be reacted with l-phenyl-1-(4-(4-(2-hydroxyethyl)piperizin-1-yl)phenyl-2-propyn-1-<br>
ol, to form indeno[2',3':3,4]naphtho[l,2-b]pyran 14. The hydroxy moiety of 14<br>
may be condensed with 2-iscyanatoethyl methacrylate to afford photochromic<br>
naphthopyran 15 having an R substituent on the B group, wherein the reactive<br>
substituent R comprises -D-J, as defined herein above, where -D- is an amino<br>
alcohol residue.<br>
[077] The photochromic materials of the present disclosure, for example<br>
photochromic materials comprising a photochromic naphthopyran and a reactive<br>
substituent bonded to the photochromic naphthopyran, wherein the reactive<br>
substituent has the structure as set forth herein, may be used in ophthalmic devices.<br>
[078] In certain non-limiting embodiments, the photochromic materials of the<br>
present disclosure may be used in soft contact lenses, hard contact lenses, intraocular<br>
lenses, overlay lenses, ocular inserts, and optical inserts.<br>
[079] The photochromic materials according to various non-limiting embodiments<br>
disclosed herein may be incorporated into an organic material, such as a polymeric,<br>
oligomeric, or monomeric material, which may be used, for example and without<br>
limitation, to form ophthalmic devices. As used herein the term "incorporated into"<br>
means physically and/or chemically combined with. Thus, the ophthalmic devices<br>
according to various non-limiting embodiments disclosed herein may be formed<br>
from photochromic materials physically and/or chemically combined with at least a<br>
portion of an organic material. As used herein the terms "polymer" and "polymeric<br>
material" refers to homopolymers and copolymers (e.g., random copolymers, block<br>
copolymers, and alternating copolymers), as well as blends and other combinations<br>
thereof. Further, it is contemplated that the photochromic materials according to<br>
various non-limiting embodiments disclosed herein may each be used alone, in<br>
combination with other photochromic materials according to various non-limiting<br>
VTN5080<br><br>
-47-<br>
embodiments disclosed herein, or in combination with other appropriate<br>
complementary conventional photochromic materials. For example, the<br>
photochromic materials according to various non-limiting embodiments disclosed<br>
herein may be used in conjunction with other complementary conventional<br>
photochromic materials having an activated absorption maxima within the range of<br>
300 to 1000 nanometers. The complementary conventional photochromic materials<br>
may include other polymerizable or compatabilized photochromic materials.<br>
[080] The present disclosure also contemplates ophthalmic devices formed from<br>
photochromic compositions comprising a polymeric material and a photochromic<br>
material according to the various non-limiting embodiments discussed herein. As<br>
used herein, the term "photochromic composition" refers to a photochromic material<br>
in combination with another material, which may or may not be a photochromic<br>
material. In certain non-limiting examples of the photochromic compositions<br>
according to various non-limiting embodiments of the present disclosure, the<br>
photochromic material is incorporated into at least a portion of the polymeric<br>
material. For example, and without limitation, the photochromic materials disclosed<br>
herein may be incorporated into a portion of the polymeric material, such as by<br>
bonding to a portion of the polymeric material, for example by co-polymerizing the<br>
photochromic material with a portion of the polymeric material; or blending with the<br>
polymeric material. As used herein, the term "blended" or "blending" mean that the<br>
photochromic material is intermixed or intermingled with at least a portion of an<br>
organic material, such as the polymeric material, but not bonded to the organic<br>
material. As used herein, the terms "bonded" or "bonding" mean that the<br>
photochromic material is linked to a portion of an organic material, such as the<br>
polymeric material, or a precursor thereof. For example, in certain non-limiting<br>
embodiments, the photochromic material may be bonded to a portion of an organic<br>
material through a reactive substituent (such, but not limited to, those reactive<br>
substituents discussed above).<br>
VTN5080<br><br>
-48-<br>
[081] According to one non-limiting embodiment, the photochromic material may<br>
be incorporated into at least a portion of the polymeric material or at least a portion<br>
of the monomeric material or oligomeric material from which the ophthalmic device<br>
is formed. For example, photochromic materials according to various non-limiting<br>
embodiments disclosed herein that have a reactive substituent may be bonded to an<br>
organic material such as a monomer, oligomer, or polymer having a group with<br>
which a reactive moiety may be reacted, or the reactive moiety can be reacted as a<br>
co-monomer in the polymerization reaction from which the organic material is<br>
formed, for example, in a co-polymerization process. As used, herein, the term "co-<br>
polymerized with" means that the photochromic material is linked to a portion of the<br>
polymeric material by reacting as a co-monomer in the polymerization reaction of<br>
the host monomers that result in the polymeric material. For example, photochromic<br>
materials according to various non-limiting embodiments herein have a reactive<br>
substituent that comprises a polymerizable moiety that may react as a co-monomer<br>
during the polymerization of the host monomers.<br>
[082] Polymeric materials suitable for the various non-limiting embodiments of the<br>
present disclosure include those suitable for the production of ophthalmic devices.<br>
[083] Further, according to various non-limiting embodiments at least a portion of<br>
the ophthalmic device is transparent. For example, according to various non-<br>
limiting embodiments, the ophthalmic device may be formed from an optically clear<br>
polymeric material. According to one specific non-limiting embodiment, the<br>
polymeric material is formed from a mixture comprising polymerizable and<br>
optionally non-polymerizable ophthalmic device forming components which are<br>
known in the art to be useful for forming ophthalmic devices, such as contact lenses.<br>
More specifically, suitable components include polymerizable monomers,<br>
prepolymers and macromers, wetting agents, UV absorbing compounds,<br>
compatibilizing components, colorants and tints, mold release agents, processing<br>
aids, mixtures thereof and the like.<br>
VTN5080<br><br>
-49-<br>
[084] According to one specific non-limiting embodiment, the ophthalmic device<br>
forming components preferably form a hydrogel upon polymerization and hydration.<br>
A hydrogel is a hydrated, crosslinked polymeric system that contains water in an<br>
equilibrium state. Hydrogels typically are oxygen permeable and biocompatible,<br>
making them preferred materials for producing ophthalmic devices and in particular<br>
contact and intraocular lenses.<br>
[085] Ophthalmic device forming components are known in the art and include<br>
polymerizable monomers, prepolymers and macromers which contain polymerizable<br>
group(s) and performance groups which provide the resulting polymeric material<br>
with desirable properties. Suitable performance groups include but are not limited to<br>
hydrophilic groups, oxygen permeability enhancing groups, UV or visible light<br>
absorbing groups, combinations thereof and the like.<br>
[086] The term "monomer" used herein refers to low molecular weight compounds<br>
(i.e. typically having number average molecular weights less than about 700).<br>
Prepolymers are medium to high molecular weight compounds or polymers (having<br>
repeating structural units and a number average molecular weight greater than about<br>
700) containing functional groups capable of further polymerization. Macromers are<br>
uncrosslinked polymers which are capable of cross-linking or further<br>
polymerization.<br>
[087] One suitable class of ophthalmic device forming components includes<br>
hydrophilic components, which are capable of providing at least about 20% and<br>
preferably at least about 25% water content to the resulting lens when combined<br>
with the remaining components. The hydrophilic components that may be used to<br>
make the polymers of this invention are monomers having at least one<br>
polymerizable double bond and at least one hydrophilic functional group. Examples<br>
of polymerizable double bonds include acrylic, methacrylic, acrylamido,<br>
methacrylamido, fumaric, maleic, styryl, isopropenylphenyl, O-vinylcarbonate, O-<br>
vinylcarbamate, allylic, O-vinylacetyl and N-vinyllactam and N-vinylamido double<br>
bonds. Non-limiting examples of hydrophilic monomers having acrylic and<br>
VTN5080<br><br>
-50-<br>
methacrylic polymerizable double bonds include N,N-dimethylacrylamide (DMA),<br>
2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, glycerol methacrylate, 2-<br>
hydroxyethyl methacrylamide, polyethyleneglycol monomethacrylate, methacrylic<br>
acid, acrylic acid and mixtures thereof.<br>
[088] Non-limiting examples of hydrophilic monomers having N-vinyl lactam and<br>
N-vinylamide polymerizable double bonds include N-vinyl pyrrolidone (NVP), N-<br>
vinyl-N-methyl acetamide, N-vinyl-N-ethyl acetamide, N-vinyl-N-ethyl formamide,<br>
N-vinyl formamide, N-2-hydroxyethyl vinyl carbamate, N-carboxy-B-alanine N-<br>
vinyl ester, with NVP and N-vinyl-N-methyl acetamide being preferred. Polymers<br>
formed from these monomers may also be included.<br>
[089] Other hydrophilic monomers that can be employed in the invention include<br>
polyoxyethylene polyols having one or more of the terminal hydroxyl groups<br>
replaced with a functional group containing a polymerizable double bond.<br>
[090] Still further examples are the hydrophilic vinyl carbonate or vinyl carbamate<br>
monomers disclosed in U.S. Pat. No.5,070,215, and the hydrophilic oxazolone<br>
monomers disclosed in U.S. Pat. No. 4,190,277. Other suitable hydrophilic<br>
monomers will be apparent to one skilled in the art.<br>
[091] Preferred hydrophilic monomers which may be incorporated into the<br>
polymerizable mixture of the present invention include hydrophilic monomers such<br>
as N,N-dimethyl acrylamide (DMA), 2-hydroxyethyl acrylate, 2-hydroxyethyl<br>
methacrylate (HEMA), glycerol methacrylate, 2-hydroxyethyl methacrylamide, N-<br>
vinylpyrrolidone (NVP), N-vinyl-N-methyl acetamide, polyethyleneglycol<br>
monomethacrylate and mixtures thereof.<br>
[092] Most preferred hydrophilic monomers include HEMA, DMA, NVP, N-vinyl-<br>
N-methyl acetamide and mixtures thereof.<br>
[093] The above references hydrophilic monomers are suitable for the production<br>
of conventional contact lenses such as those made from to etafilcon, polymacon,<br>
vifilcon, genfilcon A and lenefilcon A and the like. For a conventional contact lens<br>
the amount of hydrophilic monomer incorporated into the polymerizable mixture is<br>
VTN5080<br><br>
-51-<br>
at least about 70 weight % and preferably at least about 80 weight %, based upon the<br>
weight of all the components in the polymerizable mixture.<br>
[094] In another non-limiting embodiment, suitable contact lenses may be made<br>
from polymeric materials having increased permeability to oxygen, such as<br>
galyfilcon A, senofilcon A, balafilcon, lotrafilcon A and B and the like. The<br>
polymerization mixtures used to form these and other materials having increased<br>
permeability to oxygen, generally include one or more of the hydrophilic monomers<br>
listed above, with at least one silicone containing component.<br>
[095] A silicone-containing component is one that contains at least one [Si<br>
OSi] group, in a monomer, macromer or prepolymer. Preferably, the Si and<br>
attached O are present in the silicone-containing component in an amount greater<br>
than 20 weight percent, and more preferably greater than 30 weight percent of the<br>
total molecular weight of the silicone-containing component. Useful silicone-<br>
containing components preferably comprise polymerizable functional groups such as<br>
acrylate, methacrylate, acrylamide, methacrylamide, N-vinyl lactam, N-vinylamide,<br>
and styryl functional groups. Examples of silicone-containing components which<br>
are useful in this invention may be found in U.S. Pat. Nos. 3,808,178; 4,120,570;<br>
4,136,250; 4,153,641; 4,740,533; 5,034,461 and 5,070,215, and EP080539. All of<br>
the patents cited herein are hereby incorporated in their entireties by reference.<br>
These references disclose many examples of olefinic silicone-containing<br>
components.<br>
[096] Further examples of suitable silicone-containing monomers are<br>
polysiloxanylalkyl(meth)acrylic monomers represented by the following formula:<br>
Formula VI<br><br>
VTN5080<br><br>
-52-<br>
wherein: R30 denotes H or lower alkyl; X denotes O or NR34; each R34<br>
independently denotes hydrogen or methyl,<br>
each R31-R33 independently denotes a lower alkyl radical or a phenyl radical, and<br>
n is 1 or 3 to 10.<br>
[097] Examples of these polysiloxanylalkyl (meth)acrylic monomers include<br>
methacryloxypropyl tris(trimethylsiloxy) silane,<br>
methacryloxymethylpentamethyldisiloxane,<br>
methacryloxypropylpentamethyldisiloxane,<br>
methyldi(trimethylsiloxy)methacryloxypropyl silane, and<br>
methyldi(trimethylsiloxy)methacryloxymethyl silane. Methacryloxypropyl<br>
tris(trimethylsiloxy)silane is the most preferred.<br>
[098] One preferred class of silicone-containing components is a<br>
poly(organosiloxane) prepolymer represented by Formula VII:<br>
Formula VII<br><br>
wherein each A independently denotes an activated unsaturated group, such as an<br>
ester or amide of an acrylic or a methacrylic acid or an alkyl or aryl group<br>
(providing that at least one A comprises an activated unsaturated group capable of<br>
undergoing radical polymerization); each of R35, R36, R37 and R38 are independently<br>
selected from the group consisting of a monovalent hydrocarbon radical or a halogen<br>
substituted monovalent hydrocarbon radical having 1 to 18 carbon atoms which may<br>
have ether linkages between carbon atoms;<br>
R39 denotes a divalent hydrocarbon radical having from 1 to 22 carbon<br>
atoms, and<br>
VTN5080<br><br>
-53-<br>
m is 0 or an integer greater than or equal to 1, and preferably 5 to 400, and<br>
more preferably 10 to 300. One specific example is , -bismethacryloxypropyl<br>
poly-dimethylsiloxane. Another preferred example is mPDMS<br>
(monomethacryloxypropyl terminated mono-n-butyl terminated<br>
polydimethylsiloxane).<br>
[099] Another useful class of silicone containing components includes silicone-<br>
containing vinyl carbonate or vinyl carbamate monomers of the following formula:<br>
Formula VIII<br><br>
wherein: Y denotes O, S, or NH; RSl denotes a silicone-containing organic radical;<br>
R40 denotes hydrogen or methyl; d is 1, 2, 3 or 4; and q is 0 or 1. Suitable silicone-<br>
containing organic radicals RSl include the following:<br>
-(CH2)q'Si[(CH2)sCH3]3<br>
-(CH2VSi[OSi(CH2)sCH3]3<br><br>
wherein:<br>
Q denotes<br><br><br>
-54-<br>
wherein p is 1 to 6; R41 denotes an alkyl radical or a fluoroalkyl radical<br>
having 1 to 6 carbon atoms; e is 1 to 200; q' is 1, 2, 3 or 4; and s is 0, 1, 2, 3, 4 or 5.<br>
[100] The silicone-containing vinyl carbonate or vinyl carbamate monomers<br>
specifically include: 1,3-bis[4-(vinyloxycarbonyloxy)but-1-yl]tetramethyl-<br>
disiloxane; 3-(vinyloxycarbonylthio) propyl-[tris (trimethylsiloxy)silane]; 3-<br>
[tris(trimethylsiloxy)silyl] propyl allyl carbamate; 3-[tris(trimethylsiloxy)silyl]<br>
propyl vinyl carbamate; trimethylsilylethyl vinyl carbonate; trimethylsilylmethyl<br>
vinyl carbonate, and<br><br>
[101] The above description of silicone containing components is not an<br>
exhaustive list. Any other silicone components known in the art may be used.<br>
Further examples include, but are not limited to macromers made using group<br>
transfer polymerization, such as those disclosed in 6,367,929, polysiloxane<br>
containing polyurethane compounds such as those disclosed in US 6,858,218,<br>
polysiloxane containing macromers, such as those described as Materials A-D in US<br>
5,760,100; macromers containing polysiloxane, polyalkylene ether, diisocyanate,<br>
polyfluorinated hydrocarbon, polyfluorinated ether and polysaccharide groups, such<br>
as those described is WO 96/31792; polysiloxanes with a polar fluorinated graft or<br>
side group(s) having a hydrogen atom attached to a terminal difluoro-substituted<br>
carbon atom, such as those described in U.S. Pat. Nos. 5,321,108; 5,387,662 and<br>
5,539,016; hydrophilic siloxanyl methacrylate monomers and polysiloxane-<br>
dimethacrylate macromers such as those described in US 2004/0192872;<br>
combinations thereof and the like.<br>
VTN5080<br><br>
-55-<br>
[102] The polymerizable mixture may contain additional components such as, but<br>
not limited to, wetting agents, such as those disclosed in US 6,822,016, US Serial<br>
No. 11/057,363 (VTN 5045), US Serial No. 10/954,560, US Serial No. 10/954,559<br>
and US Serial No. 955,214; compatibilizing components, such as those disclosed<br>
inUS 6,822,016 and WO03/022322; UV absorbers, medicinal agents, antimicrobial<br>
compounds, reactive tints, pigments, copolymerizable and nonpolymerizable dyes,<br>
release agents and combinations thereof.<br>
[103] Also contemplated are copolymers of the aforementioned monomers,<br>
combinations, and blends of the aforementioned polymers and copolymers with<br>
other polymers, e.g., to form interpenetrating network products.<br>
[104] The polymerizable mixture may optionally further comprise a diluent.<br>
Suitable diluents for polymerizable mixtures are well known in the art. Non-limiting<br>
examples for polymerizable mixtures for hydrophilic soft contact lenses include<br>
organic solvents or water or mixtures hereof. Preferred organic solvents include<br>
alcohols, diols, triols, polyols and polyalkylene glycols. Examples include but are<br>
not limited to glycerin, diols such as ethylene glycol or diethylene glycol; boris acid<br>
esters of polyols such as those described in US Patents 4,680,336; 4,889,664 and<br>
5,039,459; polyvinylpyrrolidone; ethoxylated alkyl glucoside; ethoxylated bisphenol<br>
A; polyethylene glycol; mixtures of propoxylated and ethoxylated alkyl glucoside;<br>
single phase mixture of ethoxylated or propoxylated alkyl glucoside and C2-12<br>
dihydric alcohol; adducts of s-caprolactone and C2-6 alkanediols and triols;<br>
ethoxylated C3-6 alkanetriol; and mixtures of these as described in US Patents<br>
5,457,140; 5,490,059, 5,490,960; 5,498,379; 5,594,043; 5,684,058; 5,736,409;<br>
5,910,519. Diluents can also be selected from the group having a combination of a<br>
defined viscosity and Hanson cohesion parameter as described in US Patent<br>
4,680,336.<br>
[105] Non-limiting examples of diluents suitable for polymerizable mixtures for<br>
silicone hydrogel soft contact lenses include alcohols such as those disclosed in US<br>
6,020,445 and US Serial No. 10/794,399 for silicone hydrogel soft contact lenses.<br>
VTN5080<br><br>
-56-<br>
The disclosure of these and all other references cited within this application are<br>
hereby incorporated by reference. Many other suitable examples are known to those<br>
of skill in the art and are included within the scope of this invention.<br>
[106] Hard contact lenses are made from polymers that include but are not limited<br>
to polymers of poly(methyl)methacrylate, silicon acrylates, fluoroacrylates,<br>
fluoroethers, polyacetylenes, and polyimides, where the preparation of<br>
representative examples may be found in US Patents 4,540,761; 4,508,884;<br>
4,433,125 and 4,330,383. Intraocular lenses of the invention can be formed using<br>
known materials. For example, the lenses may be made from a rigid material<br>
including, without limitation, polymethyl methacrylate, polystyrene, polycarbonate,<br>
or the like, and combinations thereof. Additionally, flexible materials may be used<br>
including, without limitation, hydrogels, silicone materials, acrylic materials,<br>
fluorocarbon materials and the like, or combinations thereof. Typical intraocular<br>
lenses are described in WO 0026698, WO 00224.60, WO 9929750, WO 9927978,<br>
WO 0022459. Other ophthalmic devices, such as punctal plugs may be made from<br>
collagen and silicone elastomers.<br>
[107] Various non-limiting embodiments disclosed herein provide photochromic<br>
ophthalmic devices comprising a photochromic material according to any of the<br>
non-limiting embodiments discussed above connected to a portion of the ophthalmic<br>
device. As used herein, the term "connected to" means associated with, either<br>
directly or indirectly through another material or structure.<br>
[108] For example and without limitation, the photochromic materials disclosed<br>
herein may be connected to at least a portion of the ophthalmic device, such as by<br>
bonding the photochromic materials to at least a portion of the material from which<br>
the ophthalmic device is made, for example by co-polymerizing or otherwise<br>
bonding the photochromic materials with the ophthalmic device material; blending<br>
the photochromic materials with the ophthalmic device material; or coating the<br>
photochromic materials on at least a portion of a surface of the ophthalmic device.<br>
VTN5080<br><br>
-57-<br>
Alternatively, the photochromic material may be connected to at least a portion of<br>
the ophthalmic device such as through an intermediate coating, film or layer.<br>
[109] According to various non-limiting embodiments disclosed herein, the<br>
photochromic material may be connected to at least a portion of the ophthalmic<br>
device by incorporating the photochromic material into at least a portion of the<br>
polymeric material of the ophthalmic device, or at least a portion of the oligomeric<br>
or monomeric material from which the ophthalmic device is formed. For example,<br>
according to one non-limiting embodiment, the photochromic material may be<br>
incorporated into the polymeric material of the ophthalmic device by the cast-in-<br>
place method. Additionally or alternatively, the photochromic material may be<br>
connected with at least a portion of the polymeric material of the ophthalmic device<br>
by imbibition. Imbibition and the cast-in-place method are discussed below.<br>
[110] For example, according to one non-limiting embodiment, the ophthalmic<br>
device comprises a polymeric material and a photochromic material is bonded to at<br>
least a portion of the polymeric material. According to another non-limiting<br>
embodiment, the ophthalmic device comprises a polymeric material and a<br>
photochromic material is blended with at least a portion of the polymeric material.<br>
According to another non-limiting embodiment, the ophthalmic device comprises a<br>
polymeric material and a photochromic material is co-polymerized with at least a<br>
portion of the polymeric material. Non-limiting examples of polymeric materials<br>
that are useful in forming the substrates according to various non-limiting<br>
embodiments disclosed herein are set forth above in detail.<br>
[Ill] According to other non-limiting embodiments, the photochromic material<br>
may be connected to at least a portion of the ophthalmic device of the photochromic<br>
article as part of an at least partial coating that is connected to at least a portion of<br>
the ophthalmic device. Further, the photochromic material may be incorporated into<br>
at least a portion of the coating composition prior to application of the coating<br>
composition to the ophthalmic device, or alternatively, a coating composition may<br>
be applied to the substrate, at least partially set, and thereafter the photochromic<br>
VTN5080<br><br>
-58-<br>
material may be imbibed into at least a portion of the coating. As used herein, the<br>
terms "set" and "setting" include, without limitation, curing, polymerizing, cross-<br>
linking, cooling, and drying.<br>
[112] For example, in one non-limiting embodiment of the present disclosure, the<br>
ophthalmic device may comprise an at least partial coating of a polymeric material<br>
connected to at least a portion of a surface thereof. According to this non-limiting<br>
embodiment, the photochromic material may be blended with at least a portion of<br>
the polymeric material of the at least partial coating, or the photochromic material<br>
may be bonded to at least a portion of the polymeric material of the at least partial<br>
coating. ,According to one specific no-limiting embodiment, the photochromic<br>
material may be co-polymerized with at least a portion of the polymeric material of<br>
the at least partial coating.<br>
[113] The at least partial coating comprising a photochromic material may be<br>
directly connected to the ophthalmic device, for example, by directly applying a<br>
coating composition comprising a photochromic material to at least a portion of a<br>
surface of the ophthalmic device, and at least partially setting the coating<br>
composition. Additionally or alternatively, the at least partial coating comprising a<br>
photochromic material may be connected to the ophthalmic device, for example,<br>
through one or more additional coatings. For example, while not limiting herein,<br>
according to various non-limiting embodiments, an additional coating composition<br>
may be applied to at least a portion of the surface of the ophthalmic device, at least<br>
partially set, and thereafter the coating composition comprising a photochromic<br>
material may be applied over the additional coating and at least partially set.<br>
[114] Non-limiting examples of additional coatings and films that may be used in<br>
conjunction with the ophthalmic device disclosed herein include conventional<br>
photochromic coating and films; ophthalmically compatible coatings including clear<br>
coats, hydrophilic coatings, combinations thereof; and the like.<br>
VTN5080<br><br>
-59-<br>
[115] Non-limiting examples of conventional photochromic coatings and films<br>
include, but are not limited to, coatings and films comprising conventional<br>
photochromic materials.<br>
[116] The present disclosure also contemplates various methods of making<br>
ophthalmic devices comprising connecting a photochromic material, according to<br>
the various non-limiting embodiments disclosed herein, to at least a portion of an<br>
ophthalmic device. For example, in one non-limiting embodiment, connecting the<br>
photochromic material to at least a portion of the ophthalmic device may comprise<br>
blending the photochromic material with at least a portion of the polymeric material<br>
used to form the ophthalmic device. In another non-limiting embodiment,<br>
connecting the photochromic material to at least a portion of the ophthalmic device<br>
may comprise bonding the photochromic material to at least a portion of the<br>
polymeric material of the ophthalmic device. For example in one non-limiting<br>
embodiment, connecting the photochromic material to at least a portion of the<br>
ophthalmic device may comprise co-polymerizing the photochromic material with at<br>
least a portion of the polymeric material used to form the ophthalmic device. Non-<br>
limiting methods of connecting photochromic materials to a polymeric material<br>
include, for example, mixing the photochromic material into a solution or melt of a<br>
polymeric, oligomeric, or monomeric material, and subsequently at least partially<br>
setting the polymeric, oligomeric, or monomeric material. It will be appreciated by<br>
those skilled in the art that, according to this non-limiting embodiment, in the<br>
resultant photochromic composition, the photochromic materials may be blended<br>
with the polymeric material (i.e., intermixed with but not bonded to) or bonded to<br>
the polymeric material. For example, if the photochromic material contains a<br>
polymerizable group that is compatible with the polymeric, oligomeric, or monomer<br>
material, during setting of the organic material the photochromic material can be<br>
reacted with at least a portion thereof to bond the photochromic material thereto.<br>
[117] In another non-limiting embodiment, connecting the photochromic material<br>
to at least a portion of the ophthalmic device may comprise imbibing the<br>
VTN5080<br><br>
-60-<br>
photochromic material with at least a portion of the polymeric material of the<br>
ophthalmic device. According to this non-limiting embodiment, the photochromic<br>
material may be caused to diffuse into the polymeric material, for example, by<br>
immersing an ophthalmic device comprising a polymeric material in a solution<br>
containing the photochromic material, with or with out heating. In another non-<br>
limiting embodiment, the connecting the photochromic material to at least a portion<br>
of the ophthalmic device may comprise a combination of two or more of blending,<br>
bonding (for example co-polymerizing), and imbibing the photochromic material<br>
to/with at least a portion of the polymeric material of the ophthalmic device.<br>
[118] According to one non-limiting embodiment of the methods, wherein the<br>
substrate comprises a polymeric material, incorporating the photochromic material<br>
with at least a portion of a substrate comprises a cast-in-place method. According to<br>
this non-limiting embodiment, the photochromic material may be mixed with a<br>
polymeric solution or melt, or other oligomeric and/or monomeric solution or<br>
mixture, which is subsequently cast into a molding having a desired shape and at<br>
least partially set to form the ophthalmic device. Further, although not required<br>
according to this non-limiting embodiment, a photochromic material can be bonded<br>
to the polymeric material.<br>
[119] According to another non-limiting embodiment of the methods, wherein the<br>
ophthalmic device comprises a polymeric material, connecting the photochromic<br>
material to at least a portion of an ophthalmic device comprises in-mold casting.<br>
According to this non-limiting embodiment, a coating composition comprising the<br>
photochromic material, which may be a liquid coating composition, is applied to the<br>
surface of a mold and at least partially set. Thereafter, a polymer solution or melt, or<br>
oligomer or monomeric solution or mixture is cast over the coating and at least<br>
partially set. After setting, the ophthalmic device with the coating is removed from<br>
the mold.<br>
[120] According to still another non-limiting embodiment of the methods,<br>
connecting the photochromic material to at least a portion of a ophthalmic device<br>
VTN5080<br><br>
-61-<br>
comprises applying an at least partial coating comprising the photochromic material<br>
to at least a portion of the ophthalmic device. Non-limiting examples of suitable<br>
coating methods include dip coating, spin coating, spray coating (e.g., using a liquid<br>
coating), curtain coating, roll coating, spin and spray coating, over-molding, and the<br>
like. For example, according to one non-limiting embodiment, the photochromic<br>
material may be connected to the ophthalmic device by over-molding. According to<br>
this non-limiting embodiment, a coating composition comprising the photochromic<br>
material (which may be a liquid coating composition as previously discussed) is<br>
applied to a mold and the ophthalmic device is then placed into the mold such that<br>
the ophthalmic device contacts the coating causing it to spread over at least a portion<br>
of the surface of the ophthalmic device. Thereafter, the coating composition is at<br>
least partially set and the coated ophthalmic device is removed from the mold.<br>
Alternatively, over-molding may be done by placing the ophthalmic device into a<br>
mold such that an open region is defined between the ophthalmic device and the<br>
mold, and thereafter injecting a coating composition comprising the photochromic<br>
material into the open region. Thereafter, the coating composition can be at least<br>
partially set and the coated ophthalmic device is removed from the mold.<br>
[121] Further, it will be appreciated by those skilled in the art that the<br>
photochromic compositions, photochromic ophthalmic devices, and photochromic<br>
coating compositions according to various non-limiting embodiments disclosed<br>
herein may further comprise other additives that aid in the processing and/or<br>
performance of the composition. For example, and without limitation, such<br>
additives may include complementary photochromic materials, photoinitiators,<br>
thermal initiators, polymerization inhibitors, solvents, light stabilizers (such as, but<br>
not limited to, ultraviolet light absorbers and light stabilizers, such as hindered<br>
amine light stabilizers (HALS)), heat stabilizers, mold release agents, rheology<br>
control agents, leveling agents (such as, but not limited to, surfactants), free radical<br>
scavengers, or adhesion promoters (such as hexanediol diacrylate and coupling<br>
agents).<br>
VTN5080<br><br>
-62-<br>
[122] Each of the photochromic materials described herein may be used in amounts<br>
(or in a ratio) such that a ophthalmic device or a polymeric material to which the<br>
photochromic material is associated, i.e., blended, co-polymerized, or otherwise<br>
bonded, coated and/or imbibed, exhibits a desired resultant color, e.g., substantially<br>
clear and colorless when the photochromic material is in the closed form and<br>
substantially colored when activated by actinic radiation and the photochromic<br>
material is in the open form.<br>
[123] The amount of the photochromic naphthopyrans of the present disclosure to<br>
be connected to or incorporated into a coating composition, polymeric material,<br>
ophthalmic device, and/or photochromic composition, is not critical provided that a<br>
sufficient amount is used to produce the desired optical effect. Generally, such<br>
amount may be described as a "photochromic amount". The particular amount of<br>
photochromic material used may depend on a variety of factors such as, the<br>
absorption characteristics of the photochromic material used, the intensity of color<br>
desired upon irradiation thereof, and the method used to incorporate or apply the<br>
photochromic material.<br>
[124] The relative amounts of the aforesaid photochromic materials used in the<br>
various methods of the non-limiting embodiments of the present disclosure will vary<br>
and depend, in part, upon the relative intensities of the color of the activated species<br>
of such materials, the ultimate color desired, the molar absorption coefficient (of<br>
"extinction coefficient") for actinic radiation, and the method of application to the<br>
polymeric material or substrate. Generally, the amount of total photochromic<br>
material incorporated into or connected to a polymeric material or ophthalmic device<br>
may range from about 0.05 to about 5.0 milligrams per square centimeter of the<br>
surface to which the photochromic material is incorporated into or connected to.<br>
The amount of photochromic material incorporated into or connected to a coating<br>
composition may range from 0.1 to 40 weight percent based on the weight of the<br>
liquid coating composition. The amount of photochromic material incorporated<br>
into, i.e., blended with, co-polymerized with, or bonded to, a host polymer<br>
VTN5080<br><br>
-63-<br>
photochromic composition or photochromic ophthalmic device, such as by a in cast-<br>
in-place type method, may range from 0.01 to 40 weight percent based on the weight<br>
of the polymeric composition or photochromic ophthalmic device.<br>
EXAMPLES<br>
[125] The following examples illustrate various non-limiting embodiments of the<br>
compositions and methods within the present disclosure and are not restrictive of the<br>
invention as otherwise described herein.<br>
Example 1:<br>
Stepl<br>
[126] 2,3-Dimethoxy-7,7-dimethyl-7H-benzo[C]fluoren-5-ol (10g ), 1-phenyl-1-<br>
(4-morpholinophenyl)-2-propyn-1-ol (13 g), dodecyl benzenesulfonic acid (10<br>
drops), and chloroform (400 mL) were combined in a reaction flask. The reaction<br>
mixture was heated at reflux for 3 hours and concentrated. Acetone was added to<br>
the residue, and the slurry was filtered, yielding 18 g of off-white solid.<br>
Step 2<br>
[127] 3-Phenyl-3-(4-morpholinophenyl)-6,7-dimethoxy-13,13-dimethyl-3H,13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran from Step 1 (20 g), 3-piperidinomethanol (7.6<br>
g), and tetrahydrofuran (250 mL) were combined in a dry reaction flask cooled with<br>
ice bath under nitrogen atmosphere. Butyl lithium in hexane (2.5 M, 50 mL) was<br>
added to the reaction mixture dropwise under stirring. The cooling bath was<br>
removed after the addition and the flask was warmed to room temperature. The dark<br>
solution was poured into ice water (400 mL) and the mixture was extracted with<br>
ethyl acetate (twice with 400 mL). The organic layer was washed with saturated<br>
sodium chloride aqueous solution (200 mL), dried over sodium sulfate and<br>
concentrated. The residue was purified by silica gel chromatography (ethyl<br>
acetate/hexanes (v/v): 1/1.5). The product was obtained as an expanded brown-tinted<br>
foam (17 g).<br>
Step 3<br>
VTN5080<br><br>
-64-<br>
[128] 3 -Phenyl-3 -(4-morpholinophenyl)-6-methoxy-7-(3 -<br>
hydroxymethylenepiperidin-1 -yl)-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran from Step 2 from Step 1 (9 g), 2-<br>
isocyanatoethyl methacrylate (3 mL), dibutyltin laureate (5 drops) and ethyl acetate<br>
(200 mL) were combined in a reaction flask with a condenser open to air. The<br>
mixture was heated at reflux for 30 minutes. Methanol (15 mL) was added to the<br>
mixture to quench excess 2-isocyanatoethyl methacrylate. The reaction mixture was<br>
concentrated and the residue was purified by silica gel chromatography (ethyl<br>
acetate/hexanes (v/v): 1/1). The product was obtained as an expanded purple-tinted<br>
foam (11 g). Nuclear magnetic resonance spectroscopy ("NMR") supports the<br>
structure of 3-phenyl-3-(4-moipholinophenyl)-6-methoxy-7-(3-(2-<br>
methacryloxyethyl)carbamyloxymethylene piperidin-1 -yl)-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran.<br>
Example 2:<br>
Step 1<br>
[129] The procedure of Step 2 of Example 1 was followed except that 4-<br>
hydroxypiperidine was used in place of 3-piperidinomethanol. The product was<br>
obtained as off-white crystals.<br>
Step 2<br>
[130] The procedure of Step 3 of Example 1 was followed except that 3-phenyl-3-<br>
(4-morphlinophenyl)-6-methoxy-7-(4-hydroxypiperidin-1 -yl)-13,13 -dimethyl -<br>
3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran (from Step 1) was used in place of 3-<br>
phenyl-3-(4-morpholinophenyl)-6-methoxy-7-(3-hydroxymethylenepiperidin-1-yl)-<br>
13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran. The product was<br>
obtained as purple-tinted crystals. Mass spectrometry supports the molecular weight<br>
of 3-phenyl-3-(4-morphlinophenyl)-6-methoxy-7-(4-(2-<br>
methacryloxyethyl)carbamyloxypiperidin-1 -yl)-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran.<br>
VTN5080<br><br>
-65-<br>
Example 3:<br>
Stepl<br>
[131] The procedure of Step 2 of Example 1 was followed except that piperazine<br>
was used in place of 3-piperidinomethanol. The product was obtained as purple-<br>
tinted crystals.<br>
Step 2<br>
[132] 3-Phenyl-3-(4-morpholinophenyl)-6-methoxy-7-(4-piperazin-1 -yl)-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran from Step 1 (10 g), 2-<br>
isocyanatoethyl methacrylate (3 mL) and ethyl acetate (150 mL) were combined in<br>
a dry reaction flask open to air. The mixture was stirred at room temperature for 20<br>
minutes. Methanol (5 mL) was added to the mixture to quench excess 2-<br>
isocyanatoethyl methacrylate. The mixture was concentrated and the residue was<br>
purified by silica gel chromatography (ethyl acetate/hexanes (v/v): 1/1). After the<br>
chromatography, the product was crystallized from ethyl acetate/hexanes (v/v: 1/1)<br>
and filtered off as purple-tinted crystals (10 g). Mass spectrometry supports the<br>
molecular weight of 3-phenyl-3-(4-morpholinophenyl)-6-methoxy-7-(4-(2-<br>
methacryloxyethyl)carbamylpiperazin-1-yl)-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran.<br>
Example 4:<br>
Step 1<br>
[133] 4-Hydroxybenzophenone (100 g), 2-chloroethanol (50 g), sodium hydroxide<br>
(20 g) and water (500 mL) were combined in a reaction flask. The mixture was<br>
heated at reflux for 6 hours. The oily layer was separated and crystallized upon<br>
cooling, the crystals were washed with aqueous sodium hydroxide followed by<br>
water and dried, yielding 85 g of off-white solid. The product was used without<br>
further purification.<br>
Step 2<br>
VTN5080<br><br>
-66-<br>
[134] 4-(2-Hydroxyethoxy)benzophenone from Step 1 (30 g) was dissolved in<br>
anhydrous dimethylformamide (250 mL) in a reaction flask with overhead stirring.<br>
Sodium acetylide paste (15 g) in toluene was added to the reaction flask under<br>
vigorous stirring. After the reaction was complete, the mixture was added to water<br>
(500 mL), and the solution was extracted with ethyl ether (twice with 500 mL). The<br>
organic layers were combined and washed with saturated aqueous sodium chloride<br>
solution and dried over sodium sulfate. The solution was then filtered and<br>
concentrated, and the dark residue was purified by silica gel chromatography (ethyl<br>
acetate/hexanes (v/v): 1/1). The product was obtained as a white solid (33 g).<br>
Step 3<br>
[135] The procedure of Stepl of Example 1 was followed except that 1-phenyl-1-<br>
(4-(2-hydroxyethoxy)phenyl)-2-propyn-1-ol (from Step 2) was used in place of 1-<br>
phenyl-1-(4-morpholinophenyl)-2-propyn-1-ol. After the chromatography, the<br>
product was precipitated from ethyl acetate/hexanes (v/v: 1/1) and filtered off as a<br>
yellow-tinted solid.<br>
Step 4<br>
[136] The procedure of Step 2 of Example 1 was followed except that 3-phenyl-3-<br>
(4-(2-hydroxyethoxy)phenyl)-6,7-dimethoxy-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4] naphtho[l,2-b]pyran (from Step 3) was used in place of 3-phenyl-<br>
3-(4-morpholinophenyl)-6,7-dimethoxy-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran and piperidine was used in place of 3-<br>
piperidinomethanol. The product was obtained as a dark-green expanded foam.<br>
Step 5<br>
[137] The procedure of Step 3 of Example 1 was followed except that 3-phenyl-3-<br>
(4-(2-hydroxyethoxy)phenyl)-6-methoxy-7-piperidino-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran (from Step 4) was used in place of 3-phenyl-<br>
3-(4-morpholinophenyl)-6-methoxy-7-(3-hydroxymethylenepiperidin-1 -yl)-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran. The product was obtained<br>
VTN5080<br><br>
-67-<br>
as a yellow-tinted expanded foam. Mass spectrometry supports the molecular<br>
weight of 3-phenyl-3-(4-(2-(2-methacryloxyethyl) carbamyloxyethoxy)phenyl)-6-<br>
methoxy-7-piperidino-13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-<br>
b]pyran.<br>
Example 5:<br>
Stepl<br>
[138] 4-Fluorobenzophenone (30 g), piperazine (23 g), triethyl amine (23 mL),<br>
potassium carbonate (22 g) and dimethyl sulfoxide (50 mL) were combined into a<br>
reaction flask, the mixture was heated at reflux for 20 hours. After this time, the<br>
mixture was cooled and poured into water, the slurry was extracted with chloroform<br>
and the chloroform phase was washed with water twice and dried over sodium<br>
sulfate. The solution was concentrated to 45 g of orange oil. The product was used<br>
without further purification.<br>
Step 2<br>
[139] 4-Piperazinobenzophenone from Step 1 was dissolved in dimethylformamide<br>
(50 mL) in a reaction flask, excess amount of sodium acetylide (9 wt% in toluene)<br>
was added portion-wise. After the reaction was complete, the mixture was poured<br>
into water, the mixture was then extracted with ethyl acetate, and the organic layer<br>
was dried over sodium sulfate. The solution was filtered and concentrated. The<br>
residue was purified by silica gel chromatography (ethyl acetate/methanol (v/v):<br>
1/1), yielding 17 g of a yellow solid.<br>
Step 3<br>
[140] The procedure of Step 1 of Example 1 was followed except that 3,9-<br>
dimethoxy-7,7-dimethyl-7H-benzo[C]-fluoren-5-ol was used in place of 2,3-<br>
dimethoxy-7,7-dimethyl-7H-benzo[C]-fluoren-5-ol and l-phenyl-1-(4-<br>
piperazinophenyl)-2-propyn-1-ol was used in place of l-phenyl-1-(4-<br>
VTN5080<br><br>
-68-<br>
morpholinophenyl)-2-propyn-1-ol. After the chromatography, the product was<br>
precipitated from acetone/methanol (v/v: 1/1) and filtered off as a green-tinted solid.<br>
Step 4<br>
[141] Phenyl-3-(4-piperazinophenyl)-6,ll-dimethoxy-13,13-dimethyl-3H,13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran from Step 3 (1 g), 2-isocyanatoethyl<br>
methacrylate (1.5 mL) and ethyl acetate (30 mL) were combined in a dry reaction<br>
flask. The mixture was stirred at room temperature for 1 hour. Methanol (5 mL)<br>
was added to the quench excess 2-isocyanatoethyl methacrylate. The mixture was<br>
concentrated and the residue was purified by silica gel chromatography (ethyl<br>
acetate/hexanes (v/v): 1/1). The product was obtained as a green expanded foam.<br>
Mass spectrometry supports the molecular weight of 3-phenyl-3-(4-(4-(2-<br>
methacryloxyethyl) carbamylpiperazin-1 -yl)phenyl)-6,11 -dimethoxy-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran.<br>
Example 6:<br>
Stepl<br>
[142] 4-Fluorobenzophenone (20g) and l-(2-hydroxyethyl)piperazine (40g) were<br>
heated to 160C in 200ml of DMSO for 3 hours. The mixture was poured into water<br>
(1 L) and the solid collected by filtration. The solid was washed with water, dried,<br>
slurried in hexane, and dried again. The off-white solid (25g) was used in the next<br>
step without further purification.<br>
Step 2<br>
[143] 4-(4-(2-Hydroxyethyl)piperazin-1-yl)-benzophenone from Step 1 (25 g) was<br>
dissolved in dimethylformamide (50 mL) in a reaction flask and excess amount of<br>
sodium acetylide (9 wt% in toluene) was added portion-wise. After the reaction was<br>
complete, the mixture was poured into water, and 20 g of white solid was filtered<br>
off.<br>
Step 3<br>
VTN5080<br><br>
-69-<br>
[144] The procedure of Step 2 of Example 1 was followed except that 7,7-<br>
dimethyl-7H-benzo[C]fluoren-5-ol was used in place of 2,3-dimethoxy-7,7-<br>
dimethyl-7H-benzo[C]fluoren-5-oland l-phenyl-1-(4-(4-(2-hydroxyethylpiperazin-<br>
l-yl)phenyl)-2-propyn-1-ol (from Step 2) was used in place of l-phenyl-1-(4-<br>
morpholinophenyl)-2-propyn-1-ol. The product was isolated by column<br>
chromatography, eluting with ethyl acetate/methanol 80/20 (v/v), and crystallized<br>
from methanol as an off-white solid.<br>
Step 4<br>
[145] The procedure of Step 3 of Example 1 was followed except that 3-phenyl-3-<br>
(4-(4-(2-hydroxyethyl)piperazin-1 -yl)phenyl)-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran (from Step 3) was used in place of 3-phenyl-<br>
3-(4-morpholinophenyl)-6-methoxy-7-(3-hydroxymethylenepiperidin-1 -yl)-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran. Successive<br>
chromatographic separations with chloroform/methanol 90/10 (v/v), and with ethyl<br>
acetate/methanol 95/5 (v/v), yielded a pure oil that was isolated as a purple-tinted<br>
expanded foam. Mass spectrometry supports the molecular weight of 3-phenyl-3-(4-<br>
(4-(2-(2-methacryloxyethyl)carbamyloxyethyl)piperazin-1 -yl)phenyl)-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran.<br>
Example 7:<br>
Step 1<br>
[146] The procedure of Step 1 of Example 1 was followed except that 1-phenyl-1-<br>
(4-methoxyphenyl)-2-propyn-1-ol was used in place of l-phenyl-1-(4-<br>
morpholinophenyl)-2-propyn-1-ol. The product was obtained as off-white crystals.<br>
Step 2<br>
[147] The procedure of Step 2 of Example 1 was followed except that 3-phenyl-3-<br>
(4-methoxyphenyl)-6,7-dimethoxy-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran (from Step 1) was used in place of 3-phenyl-<br>
VTN5080<br><br>
-70-<br>
3-(4-morpholinophenyl)-6,7-dimethoxy-13,13-dimethyl-3H,13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran and 4-hydroxypiperidine was used in place of<br>
3-piperidinomethanol. After the chromatography, the product was crystallized from<br>
ethyl ether/methanol/hexanes (1/1/1), yielding yellow-tinted crystals.<br>
Step 3<br>
[148] 3-Phenyl-3-(4-methoxyphenyl)-6-methoxy-7-(4-hydroxypiperidin-1 -yl)-<br>
13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran from Step 2 (1 g),<br>
succinic anhydride (0.3 g), triethyl amine ( 0.5 mL) and toluene (20 mL) were<br>
combined in a dry reaction flask. The mixture was heated at reflux for 7 hours.<br>
Water (50 mL) was added to the solution and the mixture was partitioned. The<br>
toluene layer was washed with saturated sodium chloride aqueous solution and dried<br>
over sodium sulfate. The solution was concentrated and the residue was purified by<br>
silica gel chromatography (ethyl acetate/hexanes (v/v): 2/1), yielding 1.2 g of an<br>
expanded yellow-tinted foam.<br>
Step 4<br>
[149] 3-Phenyl-3-(4-methoxyphenyl)-6-methoxy-7-(4-(2-hydroxycarbonylethyl)<br>
carboxypiperidin-1 -yl)-13,13-dimethyl-3H, 13H-indeno [2' ,3': 3,4] naphtho [1,2-<br>
bjpyran from Step 3 (1.2 g), poly(ethylene glycol) methacrylate (average molecular<br>
weight 360, 1 mL), dicyclohexyl carbodiimide (0.7 g), 4-(dimethylamino)-pyridine<br>
(0.4 g) and methylene chloride (10 mL) were combined in a dry reaction flask. The<br>
mixture was heated at reflux for 5 hours and filtered. The solution was concentrated<br>
and the residue was purified by silica gel chromatography (ethyl acetate/hexanes<br>
(v/v): 1/1), yielding 1.8 g of oily mixture. MS indicates the major components have<br>
5 to 8 ethoxy groups in the polyethylene glycol chain including the compound 3-<br>
phenyl-3-(4-methoxyphenyl)-6-methoxy-7-(4-(2-(2-(2-(2-(2-(2-(2-<br>
methacryloxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)carbonylethyl)carboxypi<br>
peridin-1-yl)-13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran.<br>
VTN5080<br><br>
-71 -<br>
Example 8:<br>
Step 1<br>
[150] The procedure of Step 3 of Example 7 was followed except that 3-phenyl-3-<br>
(4-morpholinophenyl)-6-methoxy-7-(4-(3-hydroxymethylenepiperidin)-1 -yl)-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran (from Step 2 of Example 1)<br>
was used in place of 3-phenyl-3-(4-methoxyphenyl)-6-methoxy-7-(4-<br>
hydroxypiperidin-1 -yl)-13,13-dimethyl-3H, 13H-indeno[2' ,3' :3,4]naphtho[ 1,2-<br>
b]pyran. The product was obtained as a purple-tinted expanded foam.<br>
Step 2<br>
[151] The procedure of Step 4 of Example 7 was followed except that 3-phenyl-3-<br>
(4-morpholinophenyl)-6-methoxy-7-(4-(2-<br>
hydroxycarbonylethyl)carboxymethylenepiperidin-1 -yl)-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran (from Step 1) was used in place of 3-phenyl-<br>
3-(4-methoxyphenyl)-6-methoxy-7-(4-(2-hydroxycarbonylethyl) carboxypiperidin-<br>
l-yl)-13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran. The product<br>
was obtained as an oily mixture. Mass spectrometry indicates the major component<br>
is with 5 to 8 ethoxy groups in the ethylene glycol chain including 3-phenyl-3-(4-<br>
morpholinophenyl)-6-methoxy-7-(3-(2-(2-(2-(2-(2-(2-(2-<br>
methacryloxyethoxy)ethoxy)<br>
ethoxy)ethoxy)ethoxy)ethoxy)carbonylethyl)carboxymethylenepiperidin-1-yl)-<br>
13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran.<br>
Example 9:<br>
Step 1<br>
[152] The procedure of Step 4 of Example 4 was followed except that morpholine<br>
was used in place of 3-piperidine. After the chromatography, the product was<br>
recrystallized from t-butyl methyl ether/hexanes (2/1), yielding off-white crystals.<br>
Step 2<br>
VTN5080<br><br>
-72-<br>
[153] The procedure of Step 3 of Example 7 was followed except that 3-phenyl-3-<br>
(4-(2-hydroxyethoxy)phenyl)-6-methoxy-7-morpholino-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran (from Step 1) was used in place of 3-phenyl-<br>
3-(4-methoxyphenyl)-6-methoxy-7-(4-hydroxypiperidin-1 -yl)-13,13-dimethyl-<br>
3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran. The product was obtained as a<br>
brown expanded foam.<br>
Step 3<br>
[154] The procedure of Step 4 of Example 7 was followed except that 3-phenyl-3-<br>
(4-(2-(2-hydroxycarbonylethyl)carboxy)phenyl)-6-methoxy-7-morpholino-13,13-<br>
dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran (from Step 2) was used in<br>
place of 3-phenyl-3-(4-methoxyphenyl)-6-methoxy-7-(4-(2-<br>
hydroxycarbonylethyl)carboxypiperidin-1 -yl)-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran. The product was obtained as an oily mixture.<br>
Mass spectrometry indicates the major component is with 5 to 8 ethoxy groups in<br>
the ethylene glycol chain including 3-phenyl-3-(4-(2-(2-(2-(2-(2-(2-(2-(2-<br>
methacryloxyethoxy)ethoxy)ethoxy)<br>
ethoxy)ethoxy)ethoxy)carbonylethyl)carboxyethoxy) phenyl)-6-methoxy-7-<br>
morpholino-13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran.<br>
Example 10: Synthesis of Photochromic Polymer Test Square and Photochromic<br>
Performance Testing<br>
Photochromic Performance Testing<br>
[155] The photochromic performance of the photochromic materials of Examples<br>
1-9 was tested as follows.<br>
[156] A quantity of the photochromic material to be tested calculated to yield a 1.5<br>
x 10-3 molal solution was added to a flask containing 50 grams of a monomer blend<br>
of 4 parts ethoxylated bisphenol A dimethacrylate (BPA 2EO DMA), 1 part<br>
poly(ethylene glycol) 600 dimethacrylate, and 0.033 weight percent 2,2'-azobis(2-<br>
methyl propionitrile) (AIBN). The photochromic material was dissolved into the<br>
VTN5080<br><br>
-73-<br>
monomer blend by stirring and gentle heating. After a clear solution was obtained,<br>
it was poured into a flat sheet mold having the interior dimensions of 2.2 mm x 6<br>
inches (15.24 cm) x 6 inches (15.24 cm). The mold was sealed and placed in a<br>
horizontal airflow, programmable oven programmed to increase the temperature<br>
from 40C to 95C over a 5 hour interval, hold the temperature at 95C for 3 hours<br>
and then lower it to 60C for at least 2 hours. The methacrylate terminated<br>
photochromic dyes were copolymerized into the sheet after this period of time.<br>
After the mold was opened, the polymer sheet was cut using a diamond blade saw<br>
into 2 inch (5.1 cm) test squares.<br>
[157] The photochromic test squares prepared as described above were tested for<br>
photochromic response on an optical bench. Prior to testing on the optical bench,<br>
the photochromic test squares were exposed to 365 nm ultraviolet light for about 15<br>
minutes to cause the photochromic material to transform from the unactivated (or<br>
bleached) state to an activated (or colored) state, and then placed in a 76C oven for<br>
about 15 minutes to allow the photochromic material to revert back to the bleached<br>
state. The test squares were then cooled to room temperature, exposed to fluorescent<br>
room lighting for at least 2 hours, and then kept covered (that is, in a dark<br>
environment) for at least 2 hours prior to testing on an optical bench maintained at<br>
24C. The bench was fitted with a 300-watt xenon arc lamp, a remote controlled<br>
shutter, a KG-2 filter acting as a heat sink for the arc lamp, and neutral density<br>
filter(s). The sample holder in which the square to be tested was situated in a water<br>
bath which was kept at 23 C. A collimated beam of light from a tungsten lamp was<br>
passed through the square at a small angle (approximately 30) normal to the square.<br>
After passing through the square, the light from the tungsten lamp was directed to a<br>
collection sphere, avoiding collecting scattered light and reblend light beam. From<br>
the collection sphere the light travels via a fiber optic cable to an Ocean Optics<br>
S2000 spectrophotometer where the resulting spectrum was measured at the visible<br>
lambda max ("max-ViS") of the photochromic material being tested. The X,max-vis is the<br>
wavelength in the visible spectrum at which the maximum absorption of the<br>
VTN5080<br><br>
-74-<br>
activated (colored) form of the photochromic compound in a test square occurs. The<br>
max-vis wavelength was determined by testing the photochromic test squares in a<br>
Varian Cary 4000 UV-Visible spectrophotometer. The output signals from the<br>
detector were processed by a radiometer.<br>
[158] The saturated optical density ("Sat'd OD") for each test square was<br>
determined by opening the shutter from the xenon lamp and measuring the<br>
transmittance after exposing the test chip to UV radiation for 30 minutes. The xenon<br>
beam is set to 1 W/m2 for measurements of this class of dyes, however, in some<br>
instances, a power setting of 3 W/m2 was used. Irradiance was adjusted by varying<br>
the neutral density filter at the light source and by adjusting lamp output. The First<br>
Fade Half Life ("T1/2") is the time interval in seconds for the absorbance of the<br>
activated form of the photochromic material in the test squares to reach one half the<br>
Sat'd OD absorbance value at room temperature (24C), after removal of the source<br>
of activating light. Results for the photochromic materials tested are listed below in<br>
Table 1.<br>
Table 1: Photochromic Test Data<br><br>
VTN5080<br><br>
-75-<br>
* tested under 3W irradiation<br>
Example 11<br>
[159] Under a nitrogen atmosphere, about 100 mg of a blend of 91 % (wt) 2-<br>
hydroxyethyl methacrylate, 2.2 % methacrylic acid, 0.83 % ethyleneglycol<br>
dimethacrylate, 0.1 % trimethylolpropane trimethacrylate, 0.55 % 2,2'-<br>
azobisisobutyronitrile and 0.5 % CGI 819 (bis(2,4,6-trimethylbenzoyl)-phenyl<br>
phosphine oxide photoinitiator, commercially available from Ciba Specialty<br>
Chemicals), and 5.25 % of the photochromic compound made in Example 2, was<br>
combined with Glucam E-20 diluent (poly(oxy-l,2-ethanediyl), .alpha.-hydro-<br>
.omega.-hydroxy-, ether with methyl D-glucopyranoside, Ave. MW 1074 g/mole in<br>
a ratio of 50 weight parts, commercially available from Chemron Corporation) to 50<br>
weight parts reactive monomers, and placed into each front curve mold. Back curve<br>
molds were placed onto the front curve molds and lenses were formed by curing the<br>
mixture under visible light from fluorescent bulbs (Philips TLK03/40W) for about<br>
20 minutes at about 50C. The molds were removed from the light and placed in an<br>
oven that was heated to 70C for about 3 hours. The molds were removed from the<br>
oven and promptly pried open while still hot. The lenses were released from the<br>
molds by immersing them in an aqueous solution of 0.16 weight % disodium EDTA<br>
and 0.02 weight % Tween 80 (polyoxyethylene(20) sorbitan monooleate,<br>
commercially available from Aldrich Chemicals) at about 70C for about 30<br>
minutes. The lenses were rinsed in borate-buffered saline solution. The final lenses<br>
were uniform in shape.<br>
[160] It is to be understood that the present description illustrates aspects of the<br>
invention relevant to a clear understanding of the invention. Certain aspects of the<br>
invention that would be apparent to those of ordinary skill in the art and that,<br>
therefore, would not facilitate a better understanding of the invention have not been<br>
presented in order to simplify the present description. Although the present<br>
invention has been described in connection with certain embodiments, the present<br>
VTN5080<br><br>
-76-<br>
invention is not limited to the particular embodiments disclosed, but is intended to<br>
cover modifications that are within the spirit and scope of the invention, as defined<br>
by the appended claims.<br>
VTN5080<br><br>
-77-<br>
We claim:<br>
1. A photochromic ophthalmic device comprising a photochromic material comprising:<br>
a photochromic naphthopyran; and<br>
at least one reactive substituent bonded to the photochromic naphthopyran, wherein<br>
each reactive substituent is independently represented by one of:<br>
-A-D-E-G-J;<br>
-G-E-G-J;<br>
-D-E-G-J;<br>
-A-D-J;<br>
-D-G-J; and<br>
-D-J;<br>
wherein:<br>
(i) each -A- is independently -C(=O), -OC(=O)-, -NHC(=O)-, or -CH2-;<br>
(ii) each -D- is independently:<br>
(a)	a diamine residue or a derivative thereof, said diamine residue being an<br>
aliphatic diamine residue, a cyclo aliphatic diamine residue, a<br>
diazacycloalkane residue, an azacyclo aliphatic amine residue, a<br>
diazacrown ether residue, or an aromatic diamine residue, wherein a<br>
first amine nitrogen of said diamine residue forms a bond with -A- or<br>
the photochromic naphthopyran, and a second amine nitrogen of said<br>
diamine residue forms a bond with -E-, -G-, or -J; or<br>
(b)	an amino alcohol residue or a derivative thereof, said amino alcohol<br>
residue being an aliphatic amino alcohol residue, a cyclo aliphatic<br>
amino alcohol residue, an azacyclo aliphatic alcohol residue, a<br>
diazacyclo aliphatic alcohol residue, or an aromatic amino alcohol<br>
residue, wherein an amine nitrogen of said amino alcohol residue<br>
forms a bond with -A- or the photochromic naphthopyran, and an<br>
alcohol oxygen of said amino alcohol residue forms a bond with -E-,<br>
-G-, or -J, or said amine nitrogen of said amino alcohol residue forms a<br>
bond with -E-, -G-, or -J, and said alcohol oxygen of said amino<br>
alcohol residue forms a bond with -A- or the photochromic<br>
naphthopyran;<br>
VTN5080<br><br>
-78-<br>
(iii) each -E- is independently a dicarboxylic acid residue or a derivative thereof,<br>
said dicarboxylic acid residue being an aliphatic dicarboxylic acid residue,<br>
cycloaliphatic dicarboxylic acid residue, or an aromatic dicarboxylic acid<br>
residue, wherein a first carbonyl group of said dicarboxylic acid residue forms<br>
a bond with -G- or -D-, and a second carbonyl group of said dicarboxylic acid<br>
residue forms a bond with -G-;<br>
(iv) each -G- is independently:<br>
(a)	-[(OC2H4)x(OC3H6)y(OC4H8)z]-O-,<br>
wherein x, y, and z, are each independently a number between 0 and<br>
50, and the sum of x, y, and z ranges from 1 to 50; or<br>
(b)	a polyol residue or a derivative thereof, said polyol residue being an<br>
aliphatic polyol residue, a cyclo aliphatic polyol residue, and an<br>
aromatic polyol residue, wherein a first polyol oxygen of said polyol<br>
residue forms a bond with -E-, -D-, or the photochromic naphthopyran,<br>
and a second polyol oxygen of said polyol residue forms a bond with<br>
-E- or -J; and<br>
(v) each -J is independently a group comprising a reactive moiety or residue<br>
thereof; or -J is hydrogen, provided that if -J is hydrogen, -J is bonded to an<br>
oxygen of group -D- or -G-, forming a reactive moiety.<br>
2.	The ophthalmic device of claim 1, wherein the photochromic naphthopyran is a 2H-<br>
naphtho[l,2-b]pyran, a 3H-naphtho[2,l-b]pyran, an indeno[2',3':3,4]naphtho[l,2-b]pyran, an<br>
indeno[l',2':4,3]naphtho[2,l-b]pyran or a mixture thereof.<br>
3.	The ophthalmic deviceof claim 1, wherein each -J is independently acryl, crotyl,<br>
methacryl, 2-(methacryloxy)ethylcarbamyl, 2-(methacryloxy)ethoxycarbonyl, 4-vinylphenyl,<br>
vinyl, 1 -chlorovinyl, or epoxy.<br>
4.	The ophthalmic device of claim 1, wherein the photochromic material is purified by<br>
recrystallization.<br>
5.	An ophthalmic device comprising at least one photochromic material represented by:<br>
PC-[R]r<br>
wherein<br>
VTN5080<br><br>
-79-<br>
(a)	PC comprises a photochromic naphthopyran wherein said photochromic<br>
naphthopyran is a 2H-naphtho[l,2-b]pyran, a 3H-naphtho[2,l-b]pyran, an<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran, an indeno[l',2':4,3]naphtho[2,l-<br>
b]pyran, or a mixture thereof;<br>
(b)	r is an integer ranging from 1 to 4; and<br>
(c)	each R group is a reactive substituent independently represented by one of:<br>
-A-D-E-G-J;<br>
-G-E-G-J;<br>
-D-E-G-J;<br>
-A-D-J;<br>
-D-G-J; and<br>
-D-J;<br>
wherein:<br>
(i) each -A- is independently -C(=O)-, -OC(=O)-, -NHC(=O)-, or -CH2-;<br>
(ii) each -D- is independently:<br>
(a)	a diamine residue or a derivative thereof, said diamine residue<br>
being an aliphatic diamine residue, a cyclo aliphatic diamine<br>
residue, a diazacycloalkane residue, an azacyclo aliphatic<br>
amine residue, a diazacrown ether residue, or an aromatic<br>
diamine residue, wherein a first amine nitrogen of said diamine<br>
residue forms a bond with -A- or PC, and a second amine<br>
nitrogen of said diamine residue forms a bond with -E-, -G-, or<br>
-J; or<br>
(b)	an amino alcohol residue or a derivative thereof, said amino<br>
alcohol residue being an aliphatic amino alcohol residue, a<br>
cyclo aliphatic amino alcohol residue, an azacyclo aliphatic<br>
alcohol residue, a diazacyclo aliphatic alcohol residue, or an<br>
aromatic amino alcohol residue, wherein an amine nitrogen of<br>
said amino alcohol residue forms a bond with -A- or PC, and an<br>
alcohol oxygen of said amino alcohol residue forms a bond<br>
with -E-, -G-, or -J, or said amine nitrogen of said amino<br>
alcohol residue forms a bond with -E-, -G-, or -J, and said<br>
VTN5080<br><br>
-80-<br>
alcohol oxygen of said amino alcohol residue forms a bond<br>
with-A-or PC;<br>
(iii) each -E- is independently a dicarboxylic acid residue or a derivative<br>
thereof, said dicarboxylic acid residue being an aliphatic dicarboxylic<br>
acid residue, a cycloaliphatic dicarboxylic acid residue, or an aromatic<br>
dicarboxylic acid residue, wherein a first carbonyl group of said<br>
dicarboxylic acid residue forms a bond with -G- or -D-, and a second<br>
carbonyl group of said dicarboxylic acid residue forms a bond with -G-;<br>
(iv) each -G- is independently:<br>
(a)	-[(OC2H4)x(OC3H6)y(OC4H8)z]-O-,<br>
wherein x, y, and z, are each independently a number between<br>
0 and 50, and the sum of x, y, and z ranges from 1 to 50; or<br>
(b)	a polyol residue or a derivative thereof, said polyol residue<br>
being an aliphatic polyol residue, a cyclo aliphatic polyol<br>
residue, or an aromatic polyol residue, wherein a first polyol<br>
oxygen of said polyol residue forms a bond with -E-, -D-, or<br>
PC, and a second polyol oxygen of said polyol residue forms a<br>
bond with -E- or -J; and<br>
(v) each -J is independently a group comprising acryl, crotyl, methacryl, 2-<br>
(methacryloxy)ethylcarbamyl, 2-(methacryloxy)ethoxycarbonyl, 4-<br>
vinylphenyl, vinyl, 1-chlorovinyl, or epoxy or -J is hydrogen, provided<br>
that if -J is hydrogen, -J is bonded to an oxygen of group -D- or -G-.<br>
6.	The ophthalmic device of claim 5, wherein r is 1 or 2.<br>
7.	An ophthalmic device comprising at least one photochromic material represented by:<br>
VTN5080<br><br>
-81-<br><br>
or a mixture thereof, wherein,<br>
(a) R, is:<br>
a reactive substituent R, wherein said reactive substituent R is represented by one of:<br>
-A-D-E-G-J;<br>
-G-E-G-J;<br>
-D-E-G-J;<br>
-A-D-J;<br>
-D-G-J; and<br>
-D-J;<br>
wherein<br>
-A- is -C(=O)-, -OC(=O)-, -NHC(=O)-, or -CH2-;<br>
-D- is: a diamine residue or a derivative thereof, said diamine residue being an<br>
aliphatic diamine residue, a cyclo aliphatic diamine residue, a diazacycloalkane residue, an<br>
azacyclo aliphatic amine residue, a diazacrown ether residue, or an aromatic diamine residue,<br>
wherein a first amine nitrogen of said diamine residue forms a bond with -A-, structure I,<br>
structure II, structure III, or structure IV, and a second amine nitrogen of said diamine residue<br>
VTN5080<br><br>
-82-<br>
forms a bond with -E-, -G-, or -J; or an amino alcohol residue or a derivative thereof, said<br>
amino alcohol residue being an aliphatic amino alcohol residue, a cyclo aliphatic amino<br>
alcohol residue, an azacyclo aliphatic alcohol residue, a diazacyclo aliphatic alcohol residue,<br>
or an aromatic amino alcohol residue, wherein an amine nitrogen of said amino alcohol<br>
residue forms a bond with -A-, structure I, structure II, structure III, or structure IV, and an<br>
alcohol oxygen of said amino alcohol residue forms a bond with -E-, -G-, or -J, or said amine<br>
nitrogen of said amino alcohol residue forms a bond with -E-, -G-, or -J, and said alcohol<br>
oxygen of said amino alcohol residue forms a bond with -A-, structure I, structure II,<br>
structure III, or structure IV;<br>
-E- is a dicarboxylic acid residue or a derivative thereof, said dicarboxylic acid<br>
residue being an aliphatic dicarboxylic acid residue, a cycloaliphatic dicarboxylic acid<br>
residue, or an aromatic dicarboxylic acid residue, wherein a first carbonyl group of said<br>
dicarboxylic acid residue forms a bond with -G- or -D-, and a second carbonyl group of said<br>
dicarboxylic acid residue forms a bond with -G-;<br>
each -G- is independently: -[(OC2H4)x(OC3H6)y(OC4H8)z]-O-, wherein x, y, and z, are<br>
each independently a number between 0 and 50, and the sum of x, y, and z ranges from 1 to<br>
50; or a polyol residue or a derivative thereof, said polyol residue being an aliphatic polyol<br>
residue, a cyclo aliphatic polyol residue, or an aromatic polyol residue, wherein a first polyol<br>
oxygen of said polyol residue forms a bond with -E-, -D-, structure I, structure II, structure<br>
III, or structure IV, and a second polyol oxygen of said polyol residue forms a bond with -E-<br>
or -J; and<br>
-J is a group comprising acryl, methacryl, crotyl, 2-(methacryloxy) ethylcarbamyl, 2-<br>
(methacryloxy)ethoxycarbonyl, 4-vinylphenyl, vinyl, 1-chlorovinyl, or epoxy, or -J is<br>
hydrogen, provided that if-J is hydrogen, -J is bonded to an oxygen of group -D- or -G-;<br>
or R1 is hydrogen; hydroxyl; C1-C3 alkyl; or the group -C(=O)W, wherein W is -OR7,<br>
-N(R8)R=, piperidino or morpholino, wherein R7 is allyl, C1-C6 alkyl, phenyl, mono(C1-<br>
C6)alkyl substituted phenyl, mono(C1-C6)alkoxy substituted phenyl, phenyl(C1-C3)alkyl,<br>
mono(C1-C6)alkyl substituted phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-<br>
C3)alkyl, C1-C6 alkoxy(C2-C4)alkyl or C1-C6 haloalkyl, R8 and R9 are each independently C1-<br>
C6 alkyl, C5-C7 cycloalkyl, phenyl, mono-substituted phenyl, or di-substituted phenyl,<br>
wherein said phenyl substituents are C1-C6 alkyl or C1-C6 alkoxy, and said halo substituent is<br>
chloro or fluoro;<br>
VTN5080<br><br>
-83-<br>
(b)	R1' is: the reactive substituent R; hydrogen; hydroxy; C1-C3 alkyl; or the group<br>
-C(=O)W, wherein W is -OR7, -N(R8)R9, piperidino or morpholino, wherein R7 is allyl, C1-C6<br>
alkyl, phenyl, mono(C1-C6)alkyl substituted phenyl, mono(C1-C6)alkoxy substituted phenyl,<br>
phenyl(C1-C3)alkyl, mono(C1-C6)alkyl substituted phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy<br>
substituted phenyl(C1-C3)alkyl, C1-C6 alkoxy(C2-C4)alkyl or C1-C6 haloalkyl, and R8 and R9<br>
are each independently C1-C6 alkyl, C5-C7 cycloalkyl, phenyl, mono-substituted phenyl, or<br>
di-substituted phenyl, wherein said phenyl substituents are C1-C6 alkyl or C1-C6 alkoxy, and<br>
said halo substituent is chloro or fluoro;<br>
(c)	R2 is: the reactive substituent R; hydrogen; C1-C6 alkyl; C3-C7 cycloalkyl;<br>
substituted or unsubstituted phenyl; or -OR10; or -OC(=O)R10, wherein R10 is hydrogen, C1-<br>
C6 alkyl, phenyl(C1-C3)alkyl, mono(C1-C6)alkyl substituted phenyl(C1-C3)alkyl, mono(C1-<br>
C6)alkoxy substituted phenyl(C1-C3)alkyl, (C1-C6)alkoxy(C2-C4)alkyl, C3-C7 cycloalkyl, or<br>
mono(C1-C4)alkyl substituted C3-C7 cycloalkyl, and said phenyl substituents are C1-C6 alkyl<br>
or C1-C6 alkoxy;<br>
(d)	n is an integer ranging from 0 to 4, where R3 and R4 are independently for<br>
each occurrence: the reactive substituent R; hydrogen; fluoro; chloro; C1-C6 alkyl; C3-C7<br>
cycloalkyl; substituted or unsubstituted phenyl; -OR10; or -OC(=O)R10, wherein R10 is<br>
hydrogen, C1-C6 alkyl, phenyl(C1-C3)alkyl, mono(C1-C6)alkyl substituted phenyl(C1-<br>
C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-C3)alkyl, (C1-C6)alkoxy(C2-C4)alkyl, C3-<br>
C7 cycloalkyl, or mono(C1-C4)alkyl substituted C3-C7 cycloalkyl, and said phenyl<br>
substituents are C1-C6 alkyl or C1-C6 alkoxy; a mono-substituted phenyl, said phenyl having a<br>
substituent located at the para position, wherein the substituent is: a dicarboxylic acid residue<br>
or derivative thereof, a diamine residue or derivative thereof, an amino alcohol residue or<br>
derivative thereof, a polyol residue or a derivative thereof, -CH2-, -(CH2)t-, or -[0-(CH2)t]k-,<br>
wherein t is the integer 2, 3, 4, 5 or 6 and k is an integer from 1 to 50, the substituent being<br>
connected to an aryl group on another photochromic material; -N(Ri i)Ri2 wherein Ri 1 and<br>
R12 are each independently hydrogen, C1-C8 alkyl, phenyl, naphthyl, furanyl, benzofuran-2-<br>
yl, benzofuran-3-yl, thienyl, benzothien-2-yl, benzothien-3-yl, dibenzofuranyl,<br>
dibenzothienyl, benzopyridyl, fluorenyl, C1-C8 alkylaryl, C3-C20 cycloalkyl, C4- C20<br>
bicycloalkyl, C5- C20 tricycloalkyl or C1- C20 alkoxyalkyl, wherein said aryl group is phenyl<br>
or naphthyl, or R11 and R12 come together with the nitrogen atom to form a C3-C20 hetero-<br>
bicycloalkyl ring or a C4-C20 hetero-tricycloalkyl ring; a nitrogen containing ring represented<br>
by the following graphic formula VA:<br>
VTN5080<br><br>
-84-<br><br>
wherein each Y is independently chosen for each occurrence from -CH2-, -CH(R13)-,<br>
-C(R13)2-, -CH(aryl)-, -C(aryl)2-, and -C(R13)(aryl)-, and Z is -Y-, -O-, -S-, -S(O)-, -SO2-,<br>
-NH-, -N(R13)-, or -N(aryl)-, wherein each R13 is independently C1-C6 alkyl, each aryl is<br>
independently phenyl or naphthyl, m is an integer 1, 2 or 3, and p is an integer 0, 1, 2, or 3<br>
and when p is 0, Z is Y; a group represented by one of the following graphic formulae VB or<br>
VC: <br>
wherein R15, R16, and R17 are each independently hydrogen, C1-C6 alkyl, phenyl, or naphthyl,<br>
or the groups R15 and R16 together form a ring of 5 to 8 carbon atoms and each R14 is<br>
independently for each occurrence C1-C6 alkyl, C1-C6 alkoxy, fluoro or chloro and p is an<br>
integer 0, 1, 2, or 3; and unsubstituted, mono-, or di-substituted C4-C18 spirobicyclic amine,<br>
or unsubstituted, mono-, and di-substituted C4-C18 spirotricyclic amine, wherein said<br>
substituents are independently aryl, C1-C6 alkyl, C1-C6 alkoxy, or phenyl(C1-C6)alkyl; or<br>
an R3 group in the 6-position and an R3 group in the 7-position together form a group<br>
represented by one of VD and VE:<br><br>
wherein T and T' are each independently oxygen or the group -NRi 1-, where R11, R15, and<br>
R16 are as set forth above;<br>
(e) R5 and R6 are each independently the reactive substituent R; hydrogen;<br>
hydroxy; C1-C6 alkyl; C3-C7 cycloalkyl; allyl; substituted or unsubstituted phenyl; substituted<br>
or unsubstituted benzyl; chloro; fluoro; the group -C(=O)W', wherein W is hydrogen,<br>
hydroxy, C1-C6 alkyl, C1-C6 alkoxy, the unsubstituted, mono-or di-substituted aryl groups<br>
VTN5080<br><br>
-85-<br>
phenyl or naphthyl, phenoxy, mono- or di-( C1-C6)alkoxy substituted phenoxy, mono- or di-(<br>
C1-C6)alkoxy substituted phenoxy, amino, mono(C1-C6)alkylamino, di(C1-C6)alkylamino,<br>
phenylamino, mono- or di-(C1-C6)alkyl substituted phenylamino, or mono- or di-( C1-<br>
C6)alkoxy substituted phenylamino; -OR18, wherein R18 is C1-C6 alkyl, phenyl(C1-C3)alkyl,<br>
mono(C1-C6)alkyl substituted phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-<br>
C3)alkyl, C1-C6 alkoxy(C2-C4)alkyl, C3-C7 cycloalkyl, mono(C1-C4)alkyl substituted C3-C7<br>
cycloalkyl, C1-C6 chloroalkyl, C1-C6 fluoroalkyl, allyl, or the group -CH(R19)Y', wherein R19<br>
is hydrogen or C1-C3 alkyl and Y' is CN, CF3, or COOR20, wherein R20 is hydrogen or C1-C3<br>
alkyl, or R18 is the group, -C(=O)W", wherein W" is hydrogen, C1-C6 alkyl, C1-C6 alkoxy,<br>
the unsubstituted, mono- or di-substituted aryl groups phenyl or naphthyl, phenoxy, mono- or<br>
di-( C1-C6)alkyl substituted phenoxy, mono- or di-(C1-C6)alkoxy substituted phenoxy, amino,<br>
mono(C1-C6)alkylamino, di(C1-C6)alkylamino, phenylamino, mono- or di-(C1-C6)alkyl<br>
substituted phenylamino, or mono- or di-(C1-C6)alkoxy substituted phenylamino, wherein<br>
each of said phenyl, benzyl, or aryl group substituents are independently C1-C6 alkyl or C1-C6<br>
alkoxy; or a mono-substituted phenyl, said phenyl having a substituent located at the para<br>
position, wherein the substituent is: a dicarboxylic acid residue or derivative thereof, a<br>
diamine residue or derivative thereof, an amino alcohol residue or derivative thereof, a polyol<br>
residue or derivative thereof, -CH2-, -(CH2)t-, or -[O-(CH2)t]k-, wherein t is from an integer 2,<br>
3, 4, 5 or 6 and k is an integer from 1 to 50, the substituent being connected to an aryl group<br>
on another photochromic material; or R5 and R6 together form an oxo group, a spiro-<br>
carbocyclic group containing 3 to 6 carbon atoms, or a spiro-heterocyclic group containing 1<br>
to 2 oxygen atoms and 3 to 6 carbon atoms including the spirocarbon atom, said spiro-<br>
carbocyclic and spiro-heterocyclic groups being annellated with 0, 1 or 2 benzene rings; and<br>
(f) B and B' are each independently a substituted phenyl; a substituted aryl; a substituted<br>
9-julolindinyl; a substituted heteroaromatic group chosen from pyridyl, furanyl, benzofuran-<br>
2-yl, benzofuran-3-yl, thienyl, benzothien-2-yl, benzothien-3-yl, dib'enzofuranyl,<br>
dibenzothienyl, carbazoyl, benzopyridyl, indolinyl, and fluorenyl, wherein the phenyl, aryl,<br>
9-julolindinyl, or heteroaromatic substituent is the reactive substituent R; an unsubstituted,<br>
mono-, di-, or tri-substituted phenyl or aryl group; 9-julolidinyl; or an unsubstituted, mono-<br>
or di-substituted heteroaromatic group chosen from pyridyl, furanyl, benzofuran-2-yl,<br>
benzofuran-3-yl, thienyl, benzothien-2-yl, benzothien-3-yl, dibenzofuranyl, dibenzothienyl,<br>
carbazoyl, benzopyridyl, indolinyl, and fluorenyl, wherein each of the phenyl, aryl and<br>
heteroaromatic substituents are each independently: hydroxyl, a group -C(=O)R21, wherein<br>
VTN5080<br><br>
-86-<br>
R21 is -OR22, -N(R23)R24, piperidino, morpholino, wherein R22 is allyl, C1-C6 alkyl, phenyl,<br>
mono(C1-C6)alkyl substituted phenyl, mono(C1-C6)alkoxy substituted phenyl, phenyl(Cr<br>
C3)alkyl, mono(C]-C6)alkyl substituted phenyl(C1-C3)alkyl, mono(C1-C6)alkoxy substituted<br>
phenyl(C1-C3)alkyl, C1-C6 alkoxy(C2-C4)alkyl or C1-C6 haloalkyl, R23 and R24 are each<br>
independently C1-C6 alkyl, C5-C7 cycloalkyl, phenyl or substituted phenyl, the phenyl<br>
substituents being C1-C6 alkyl or C1-C6 alkoxy, and said halo substituent is chloro or fluoro,<br>
aryl, mono(C1-C12)alkoxyaryl, di(C1-C12)alkoxyaryl, mono(C1-C12)alkylaryl, di(C1-<br>
C12)alkylaryl, haloaryl, C3-C7 cycloalkylaryl, C3-C7 cycloalkyl, C3-C7 cycloalkyloxy, C3-C7<br>
cycloalkyloxy(C1-C12)alkyl, C3-C7 cycloalkyloxy(C1-C12)alkoxy, aryl(C1-C12)alkyl, aryl(C1-<br>
C12)alkoxy, aryloxy, aryloxy(C1-C12)alkyl, aryloxy(C1-C12)alkoxy, mono- or di(C1-<br>
C12)alkylaryl(C1-C12)alkyl, mono- or di-(C1-C12)alkoxyaryl(C1-C12)alkyl, mono- or di-(C1-<br>
C12)alkylaryl(C1-C12)alkoxy, mono- or di-(C1-C12)alkoxyaryl(C1-C12)alkoxy, amino, mono-<br>
or di-(C1-C12)alkylamino, diarylamino, piperazino, N-(C1-C12)alkylpiperazino, N-<br>
arylpiperazino, aziridino, indolino, piperidino, morpholino, thiomorpholino,<br>
tetrahydroquinolino, tetrahydroisoquinolino, pyrrolidyl, C1-C12 alkyl, C1-C12 haloalkyl, C1-<br>
C12 alkoxy, mono(C1-C12 )alkoxy(C1-C12 )alkyl, acryloxy, methacryloxy, or halogen; an<br>
unsubstituted or mono-substituted group chosen from pyrazolyl, imidazolyl, pyrazolinyl,<br>
imidazolinyl, pyrrolinyl, phenothiazinyl, phenoxazinyl, phenazinyl, and acridinyl, each of<br>
said substituents being C1-C12 alkyl, C1-C12 alkoxy, phenyl, or halogen; a mono-substituted<br>
phenyl, said phenyl having a substituent located at the para position, wherein the substituent<br>
is: a dicarboxylic acid residue or derivative thereof, a diamine residue or derivative thereof,<br>
an amino alcohol residue or derivative thereof, a polyol residue or derivative thereof, -CH2-, -<br>
(CH2V, or -[O-(CH2)t]k-, wherein t is an integer 2, 3, 4, 5 or 6 and k is an integer from 1 to<br>
50, the substituent being connected to an aryl group on another photochromic material; a<br>
group represented by one of:<br><br>
wherein K is -CH2- or -O-, and M is -O- or substituted nitrogen, provided that when M is<br>
substituted nitrogen, K is -CH2-, the substituted nitrogen substituents being hydrogen, C1-C12<br>
alkyl, or C1-C12 acyl, each R25 being independently chosen for each occurrence from C1-C12<br>
alkyl, C1-C12 alkoxy, hydroxy, and halogen, R26 and R27 each being independently hydrogen<br>
or C1-C12 alkyl, and u is an integer ranging from 0 to 2; or a group represented by:<br>
VTN5080<br><br>
-87-<br><br>
wherein R28 is hydrogen or C1-C12 alkyl, and R29 is an unsubstituted, mono-, or di-substituted<br>
group chosen from naphthyl, phenyl, furanyl, and thienyl, wherein the substituents are C1-C12<br>
alkyl, C1-C12 alkoxy, or halogen; or<br>
B and B' taken together form one of a fluoren-9-ylidene, mono-, or di-substituted<br>
fluoren-9-ylidene, each of said fluoren-9-ylidene substituents being independently chosen<br>
from C1-C12 alkyl, C1-C12 alkoxy, and halogen;<br>
provided that the photochromic material comprises at least one reactive substituent R.<br>
8.	The ophthalmic device of claim 7, wherein the photochromic material comprises two<br>
reactive substituents R.<br>
9.	The ophthalmic device of claim 7, wherein R3 comprises a substituent at the 6 and 7<br>
position on structure III or structure IV, said substituent at the 6 and 7 position each being<br>
independently the reactive substituent R; -OR10, wherein R10 is hydrogen; C1-C6 alkyl; or a<br>
nitrogen-containing group, wherein said nitrogen-containing group is:<br>
(i) -N(R11)R12 wherein R11 and R12 are each independently hydrogen, C1-C8 alkyl,<br>
phenyl, or C1- C20 alkoxyalkyl, or<br>
(ii) a nitrogen containing ring represented by the following graphic formula VA:<br><br>
wherein each Y is independently chosen for each occurrence from -CH2-, -CH(R13)-,<br>
-C(R13)2-, -CH(aryl)-, -C(aryl)2-, and -C(R13)(aryl)-, and Z is -Y-, -O-, -S-, -S(O)-, -SO2-,<br>
-NH-, -N(R13)-, or -N(aryl)-, wherein each R13 is independently C1-C6 alkyl, each aryl is<br>
independently phenyl or naphthyl, m is the integer 1, 2 or 3, and p is the integer 0, 1, 2, or 3<br>
and when p is 0, Z is Y.<br>
10.	The ophthalmic deviceof claim 7, wherein R5 and R6 are each independently the<br>
reactive substituent R; C1-C6 alkyl; hydroxy; or -OR18, wherein R18 is C1-C6 alkyl.<br>
VTN5080<br><br>
-88-<br>
11.	The ophthalmic device of claim 1 wherein said device is formed from at least one<br>
polymeric material comprising said photochromic material incorporated into at least a portion<br>
thereof.<br>
12.	The ophthalmic device of claim 11, wherein the polymeric material is is formed from<br>
components comprising hydrophilic monomers, hydrophilic polymers and silicone<br>
components.<br>
13.	The ophthalmic device of claim 11, wherein said ophthalmic device is a contact lens<br>
and said polymeric material comprises a hydrogel.<br>
14.	The ophthalmic device of claim 1 wherein the photochromic material is connected to<br>
at least a portion of the ophthalmic device.<br>
15.	The photochromic article of claim 14, wherein the ophthalmic device is selected from<br>
the group consisting of soft contact lenses, hard contact lenses, intraocular lenses, overlay<br>
lenses, ocular inserts, and optical inserts.<br>
16.	The ophthalmic deviceof claim 1, wherein the ophthalmic device is a soft contact<br>
lens.<br>
17.	The photochromic article of claim 14, wherein the ophthalmic devicecomprises a<br>
polymeric material and the photochromic material is at least one of blended with at least a<br>
portion of the polymeric material and bonded to at least a portion of the polymeric material.<br>
18.	The ophthalmic device of claim 17, wherein the photochromic material is bonded by<br>
co-polymerization with at least a portion of the polymeric material.<br>
19.	The ophthalmic deviceof claim 17 wherein an at least partial coating of a polymeric<br>
coating material is connected to at least a portion of a surface of the ophthalmic deviceand the<br>
polymeric coating material comprises the photochromic material.<br>
20.	A method of making a photochromic ophthalmic device of claim 1 comprising<br>
connecting the photochromic material to at least a portion of the ophthalmic device.<br>
21.	The method according to claim 20, wherein the substrate comprises a polymeric<br>
material, and connecting comprises incorporating the photochromic material into at least a<br>
portion of the ophthalmic deviceby at least one of blending the photochromic material with at<br>
least a portion of the polymeric material and bonding the photochromic material to at least a<br>
portion of the polymeric material.<br>
VTN5080<br><br>
-89-<br>
22.	The method according to claim 21, wherein the photochromic material is bonded by<br>
co-polymerizing the photochromic material with at least a portion of the polymeric material.<br>
23.	The method according to claim 20, wherein the ophthalmic devicecomprises a<br>
polymeric material and connecting the photochromic material into at least a portion of said<br>
ophthalmic device comprises casting-in-place the photochromic material and the polymeric<br>
material.<br>
24.	The method according to claim 20, wherein the ophthalmic devicecomprises a<br>
polymeric material and connecting a photochromic material to at least a portion of the<br>
ophthalmic device, comprises applying an at least partial coating comprising the<br>
photochromic material to at least a portion of the ophthalmic device.<br>
25.	The method according to claim 24, wherein applying the at least partial coating<br>
comprising the photochromic material to at least a portion of the ophthalmic device<br>
comprises one of dip coating, spin coating, roll coating, spray coating, curtain coating, and<br>
in-mold casting.<br>
26.	An ophthalmic device comprising at least one photochromic material chosen from:<br>
(i) 3,3-di(4-methoxyphenyl)-6-methoxy-7-(3-(2-methacryloxyethyl)carbamyloxy<br>
methylenepiperidin-1 -yl)-l 3,13-dimethyl-3H, 13H-indeno[2' ,3' :3,4]naphtho<br>
[l,2-b]pyran;<br>
(ii) 3 -phenyl-3 -(4-morpholinophenyl)-6-methoxy-7-(3 -(2-methacryloxyethyl)<br>
carbamyloxymethylenepiperidin-1 -yl)-13,13-dimethyl-3H, 13H-indeno<br>
[2',3':3,4] naphtho[l,2-b]pyran;<br>
(iii) 3-phenyl-3-(4-(4-phenylpiperazino)phenyl)-6-methoxy-7-(4-(2-<br>
methacryloxyethyl)carbamyloxypiperidin-1 -yl)-l 3,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(iv) 3-(4-fluorophenyl)-3-(4-methoxyphenyl)-6-methoxy-7-(4-(2-<br>
methacryloxyethyl) carbamyloxypiperidin-1 -yl)-13,13-dimethyl-3H, 13H-<br>
indeno [2' ,3': 3,4] naphtho [ 1,2 -b] pyran;<br>
(v) 3-(4-fluorophenyl)-3-(4-morpholinophenyl)-6-methoxy-7-(4-(2-<br>
methacryloxyethyl)carbamyloxypiperidin-1 -yl)-13,13-dimethyl-3H, 13H-<br>
indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
VTN5080<br><br>
VTN5080<br><br>
-90-<br>
(vi) 3-phenyl-3-(4-morpholinophenyl)-6-methoxy-7-(4-(2-methacryloxyethyl)<br>
carbamyloxypiperidin-1 -yl)-13,13 -dimethyl-3H, 13H-indeno [2' ,3': 3,4] naphtho<br>
[l,2-b]pyran;<br>
(vii) 3-phenyl-3-(4-morpholinophenyl)-6-methoxy-7-(4-(2-methacryloxyethyl)<br>
carbamylpiperazin-1 -yl)-13,13-dimethyl-3H, 13H-indeno [2' ,3': 3,4] naphtho<br>
[l,2-b]pyran;<br>
(viii) 3-phenyl-3-(4-(2-(2-methacryloxyethyl)carbamyloxyethoxy)phenyl)-6-<br>
methoxy-7-piperidino-13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-<br>
b]pyran;<br>
(ix) 3 -phenyl-3 -(4-methoxyphenyl)-6-methoxy-7-(4-(2-methacryloxy ethyl)<br>
carbamylpiperazin-1-yl)-13,13-dimethyl-3H,13H-indeno[2',3':3,4]<br>
naphthofl ,2-b]pyran;<br>
(x) 3-phenyl-3-(4-(2-(2-methacryloxyethyl)carbamyloxyethoxy)phenyl)-6,7-<br>
dimethoxy-13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(xi) 3-phenyl-3-(4-(4-(2-methacryloxyethyl)carbamylpiperazin-1 -yl)phenyl)-6,11 -<br>
dimethoxy-13,13 -dimethyl-3H, 13H-indeno [2' ,3': 3,4]naphtho [ 1,2-b]pyran;<br>
(xii) 3-phenyl-3-(4-(2-methacryloxyethyl)carbamyloxyphenyl)-6,7-dimethoxy-<br>
13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(xiii) 3-phenyl-3-(4-moipholinophenyl)-6-methoxy-7-(3-(2-(2-(2-(2-(2-(2-(2-<br>
methacryloxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)carbonylethyl)<br>
carboxymethylenepiperidin-1 -yl)-13,13 -dimethyl-3H, 13H-indeno [2' ,3': 3,4]<br>
naphtho [ 1,2-b]pyran;<br>
(xiv) 3-phenyl-3-(4-methoxyphenyl)-6-methoxy-7-(3-(2-(2-(2-(2-(2-(2-(2-<br>
methacryloxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)carbonylethyl)<br>
carboxymethylenepiperidin-1 -yl)-13,13-dimethyl-3H, 13H-indeno [2' ,3': 3,4]<br>
naphtho [1,2-b] pyran;<br>
(xv) 3-phenyl-3-(4-morpholinophenyl)-6-methoxy-7-(4-(2-(2-(2-(2-(2-(2-(2-<br>
methacryloxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)carbonylethyl)<br>
carboxypiperidin-1-yl)-13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-<br>
b]pyran;<br>
(xvi) 3-phenyl-3-(4-methoxyphenyl)-6-methoxy-7-(4-(2-(2-(2-(2-(2-(2-(2-<br>
methacryloxyethoxy)ethoxy)ethoxy)ethox.y)ethoxy)ethoxy)carbonylethyl)<br><br>
-91 -<br>
carboxypiperidin-1-yl)-13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-<br>
b]pyran;<br>
(xvii) 3-phenyl-3-(4-(2-(2-(2-(2-(2-(2-(2-(2-methacryloxyethoxy)ethoxy)ethoxy)<br>
ethoxy)ethoxy)ethoxy)carbonylethyl)carboxyethoxy)phenyl)-6-methoxy-7-<br>
morpholino-13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
(xviii) 3 -phenyl-3 -(4-(4-(2-(2-methacryloxyethyl)carbamyloxyethyl)piperazin-1 -<br>
yl)phenyl)-13,13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[l,2-b]pyran;<br>
and combinations thereof.<br>
27.	The photochromic composition of claim 11 where the photochromic article<br>
comprises at least one of a complementary photochromic material, a photoinitiator, a thermal<br>
initiator, a polymerization inhibitor, a solvent, a light stabilizer, a heat stabilizer, a mold<br>
release agent, a rheology control agent, a leveling agent, a free radical scavenger, an adhesion<br>
promoter, a wetting agent, a compatibilizing component, a medicinal agent, an antimicrobial<br>
compound, a reactive tint, a pigment, a copolymerizable and nonpolymerizable dye and<br>
mixtures thereof.<br>
28.	The photochromic composition of claim 14 where the photochromic article<br>
comprises at least one of a complementary photochromic material, a photoinitiator, a thermal<br>
initiator, a polymerization inhibitor, a solvent, a light stabilizer, a heat stabilizer, a mold<br>
release agent, a rheology control agent, a leveling agent, a free radical scavenger, an adhesion<br>
promoter, a wetting agent, a compatibilizing component, a medicinal agent, an antimicrobial<br>
compound, a reactive tint, a pigment, a copolymerizable and nonpolymerizable dye and<br>
mixtures thereof.<br>
29.	The ophthalmic device of claim 14 wherein said device is coated with a coating<br>
composition comprising the photochromic material.<br><br>
VTN5080<br><br>
Various non-limiting embodiments of the present disclosure relate to<br>
ophthalmic devices comprising photochromic materials comprising a reactive substituent.<br>
For example, the present disclosure contemplates ophthalmic devices comprising<br>
photochromic materials, such as photochromic naphthopyrans and indeno-fused<br>
naphthopyrans having a reactive substituent comprising a reactive moiety linked to the<br>
photochromic naphthopyran by one or more linking groups. In certain non-limiting<br>
embodiments, the reactive moiety comprises a polymerizable moiety. In other non-limiting<br>
embodiments, the reactive moiety comprises a nucleophilic moiety. Other non-limiting<br>
embodiments of the present disclosure relate to methods of making the photochromic<br>
ophthalmic device, wherein the photochromic ophthalmic devices comprise the photochromic<br>
naphthopyrans described herein.</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1hYnN0cmFjdC5wZGY=" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1hc3NpZ25tZW50LnBkZg==" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-assignment.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1jbGFpbXMucGRm" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1jb3JyZXNwb25kZW5jZSBvdGhlcnMgMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-correspondence others 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1jb3JyZXNwb25kZW5jZSBvdGhlcnMgMS4yLnBkZg==" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-correspondence others 1.2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1jb3JyZXNwb25kZW5jZSBvdGhlcnMucGRm" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-correspondence others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1kZXNjcmlwdGlvbiBjb21wbGV0ZS5wZGY=" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-description complete.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1kcmF3aW5ncy5wZGY=" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-drawings.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1mb3JtIDEucGRm" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1mb3JtIDIucGRm" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-form 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1mb3JtIDMucGRm" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1mb3JtIDUucGRm" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1ncGEucGRm" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-gpa.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1pbnRlcm5hdGlvbmFsIHB1YmxpY2F0aW9uLnBkZg==" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-international publication.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1pbnRlcm5hdGlvbmFsIHNlYXJjaCByZXBvcnQucGRm" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-international search report.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM4MDUta29sbnAtMjAwNy1wY3QgcmVxdWVzdCBmb3JtLnBkZg==" target="_blank" style="word-wrap:break-word;">03805-kolnp-2007-pct request form.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgwMi0wMi0yMDE1KS1DT1JSRVNQT05ERU5DRS5wZGY=" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(02-02-2015)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgwMi0xMi0yMDExKS1DT1JSRVNQT05ERU5DRS5wZGY=" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(02-12-2011)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgwMi0xMi0yMDExKS1GT1JNLTMucGRm" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(02-12-2011)-FORM-3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgyOS0wOC0yMDEyKS1BQlNUUkFDVC5wZGY=" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(29-08-2012)-ABSTRACT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgyOS0wOC0yMDEyKS1BTUFOREVEIENMQUlNUy5wZGY=" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(29-08-2012)-AMANDED CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgyOS0wOC0yMDEyKS1BTk5FWFVSRSBUTyBGT1JNIDMucGRm" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(29-08-2012)-ANNEXURE TO FORM 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgyOS0wOC0yMDEyKS1ERVNDUklQVElPTiAoQ09NUExFVEUpLnBkZg==" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(29-08-2012)-DESCRIPTION (COMPLETE).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgyOS0wOC0yMDEyKS1EUkFXSU5HUy5wZGY=" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(29-08-2012)-DRAWINGS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgyOS0wOC0yMDEyKS1FWEFNSU5BVElPTiBSRVBPUlQgUkVQTFkgUkVDSUVWRUQuUERG" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(29-08-2012)-EXAMINATION REPORT REPLY RECIEVED.PDF</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgyOS0wOC0yMDEyKS1GT1JNLTEucGRm" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(29-08-2012)-FORM-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgyOS0wOC0yMDEyKS1GT1JNLTIucGRm" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(29-08-2012)-FORM-2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgyOS0wOC0yMDEyKS1PVEhFUlMucGRm" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(29-08-2012)-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LSgyOS0wOC0yMDEyKS1QRVRJVElPTiBVTkRFUiBSVUxFIDEzNy5wZGY=" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-(29-08-2012)-PETITION UNDER RULE 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LUNPUlJFU1BPTkRFTkNFIE9USEVSUyAxLjMucGRm" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-CORRESPONDENCE OTHERS 1.3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3LUZPUk0gMjYucGRm" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007-FORM 26.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3XzEtKDI5LTA4LTIwMTIpLUFOTkVYVVJFIFRPIEZPUk0gMy5wZGY=" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007_1-(29-08-2012)-ANNEXURE TO FORM 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3XzEtKDI5LTA4LTIwMTIpLUNPUlJFU1BPTkRFTkNFLnBkZg==" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007_1-(29-08-2012)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3XzEtKDI5LTA4LTIwMTIpLURFU0NSSVBUSU9OIChDT01QTEVURSkucGRm" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007_1-(29-08-2012)-DESCRIPTION (COMPLETE).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3XzEtKDI5LTA4LTIwMTIpLUVYQU1JTkFUSU9OIFJFUE9SVCBSRVBMWSBSRUNFSVZFRC5wZGY=" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007_1-(29-08-2012)-EXAMINATION REPORT REPLY RECEIVED.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3XzEtKDI5LTA4LTIwMTIpLUZPUk0tMS5wZGY=" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007_1-(29-08-2012)-FORM-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzgwNS1LT0xOUC0yMDA3XzEtKDI5LTA4LTIwMTIpLUZPUk0tMi5wZGY=" target="_blank" style="word-wrap:break-word;">3805-KOLNP-2007_1-(29-08-2012)-FORM-2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=YWJzdHJhY3QtMDM4MDUta29sbnAtMjAwNy5qcGc=" target="_blank" style="word-wrap:break-word;">abstract-03805-kolnp-2007.jpg</a></p>
		<br>
		<div class="pull-left">
			<a href="265387-process-for-the-preparation-of-ubihydroquinones-and-ubiquinones.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="265389-turbo-decoder-and-iteration-stopping-method-thereof.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>265388</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>3805/KOLNP/2007</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>09/2015</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>27-Feb-2015</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>23-Feb-2015</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>08-Oct-2007</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>JOHNSON &amp; JOHNSON VISION CARE, INC.</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>7500 CENTURION PARKWAY, SUITE 100 JACKSONVILLE, FL</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>WENJING XIAO</td>
											<td>3142 BARBERRY COURT, MURRYSVILLE, PENNSYLVANIA 15668</td>
										</tr>
										<tr>
											<td>2</td>
											<td>SHIVKUMAR MAHADEVAN</td>
											<td>1543 WILDFERN DRIVE, ORANGE PARK, FLORIDA 32003</td>
										</tr>
										<tr>
											<td>3</td>
											<td>FRANK MOLOCK</td>
											<td>1905 WHITE DOGWOOD LANE, ORANGE PARK, FLORIDA 32003</td>
										</tr>
										<tr>
											<td>4</td>
											<td>BARRY VAN GEMERT</td>
											<td>432 ELEANOR STREET, PITCAIRN, PENNSYLVANIA 15140</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>G02B 5/23</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/US2006/013005</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2006-04-03</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>11/101,979</td>
									<td>2005-04-08</td>
								    <td>U.S.A.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/265388-ophthalmic-devices-comprising-photochromic-materials-with-reactive-substituents by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 04:27:31 GMT -->
</html>
